Manuscript: Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization

efficacy study

Authors: Choo Hock Tan*, Jia Lee Liew, Kae Yi Tan, and Nget Hong Tan

Supplementary File Table S1. Mass spectrometric information of SABU (Serum Anti Bisa Ular) derived from LC-MS/MS.

Peaks 1 & 2
Database Protein Name z Score Fwd- SPI Spectral Sequence RT Average m/z Measured MH+ Mass MH+ Error Protein % in
Accession Rev (%) Intensity (min) Chi (Da) Shift (Da) (ppm) a fraction
Score Squated

F6RI47 Uncharacterized 3 15.51 15.51 76.4 7.13E+04 (R)KYSNPSNCFGR(E) 4.6 0.99 443.8672 -0.0134 -10.1 4.74%
protein
(alpha-2- 2 13.62 13.62 72.6 5.22E+04 (R)KYSNPSNCFGR(E) 4.6 1 665.2979 -0.0119 -9
macroglobulin-
like)
2 18.8 18.8 83.4 3.72E+05 (K)YSNPSNCFGR(E) 4.95 0.99 601.2521 -0.0086 -7.1
3 15.33 15.33 95 3.79E+05 (R)EIHVSEPPTETVR(K) 5.3 0.99 498.5877 -0.0109 -7.3
2 18.12 18.12 99 1.82E+05 (R)EIHVSEPPTETVR(K) 5.3 0.99 747.3788 -0.0091 -6.1
2 16.65 16.65 74.3 6.31E+05 (K)FSQQLNNQGCLSQQVK( 5.55 1 939.9541 -0.0117 -6.3
T)
2 21.1 12.35 87.5 5.05E+05 (K)IQEEGTEVELTGR(G) 5.6 0.98 730.8607 -0.0086 -5.9
2 15.31 4.56 81.3 4.53E+05 (R)IAQWQNLK(L) 5.83 0.99 500.779 -0.0067 -6.7
3 15.02 15.02 86.6 1.77E+05 (K)SFVHLEPMPR(E) 6.52 1 404.8749 -0.0092 -7.6
2 15.55 15.55 76.2 1.38E+05 (K)SFVHLEPMPR(E) 6.53 1 606.8098 -0.0071 -5.8
4 11.3 1.71 78.4 1.82E+04 (K)ESLVFVQTDKPIYKPGQT 6.7 0.89 570.0652 -0.0099 -4.4
VK(F)
3 16.76 8.84 95.8 2.15E+05 (K)ESLVFVQTDKPIYKPGQT 6.63 0.99 759.7523 -0.0066 -2.9
VK(F)
3 13.74 13.74 77.1 1.47E+05 (K)MVSGFVPLKPTVK(T) 6.83 1 468.273 -0.0082 -5.9
2 11.56 11.56 76.4 5.12E+04 (K)MVSGFVPLKPTVK(T) 6.83 1 701.9064 -0.0071 -5.1
2 15.16 5.84 87.9 6.17E+04 (R)EVLESLTEEAVK(E) 7.08 0.97 673.8528 -0.0066 -4.9
2 20.58 20.58 93.1 5.10E+04 (R)NVYINGIMYSPVSNTNE 7.37 0.86 1021.9881 -0.0162 -8
K(D)
3 20.12 12.69 97.9 9.16E+05 (K)VDLSFSPAQSLPGSPAHL 7.47 0.99 660.346 -0.0111 -5.6
R(V)
2 19.93 19.93 93.2 1.90E+05 (K)VDLSFSPAQSLPGSPAHL 7.47 0.98 990.0164 -0.009 -4.5
R(V)
2 14.19 6.65 74.9 1.61E+05 (K)DIYSFLK(D) 7.9 1 443.2362 -0.0065 -7.4
2 21.9 21.9 87.5 2.02E+05 (K)AGALCLSSGAGLGLSPT 7.93 0.97 980.017 -0.0061 -3.1
ASLR(A)
3 16.47 8.57 84.6 1.03E+05 (K)AGALCLSSGAGLGLSPT 7.92 0.95 653.6791 -0.01 -5.1
ASLR(A)
2 19.67 13.53 100 3.44E+05 (R)VSVNLEESPAFLAVPGEK 8.28 0.99 943.4953 -0.0072 -3.8
(E)
2 12.57 12.57 77.6 5.42E+05 (K)QLTFPLSSEPFQGSYK(V) 8.32 0.98 914.9558 -0.0073 -4
3 13.82 13.82 78.2 8.66E+04 (K)QLTFPLSSEPFQGSYK(V) 8.32 0.99 610.304 -0.0141 -7.7
2 15.31 15.31 88 3.37E+05 (R)LLVYTILPDGEVVGDSA 8.5 0.99 945.013 -0.0079 -4.2
K(Y)
3 17.15 17.15 91.1 1.37E+05 (R)LLVYTILPDGEVVGDSA 8.5 0.98 630.3431 -0.0119 -6.3
K(Y)
3 16.61 16.61 88.3 6.73E+03 (R)GHFSVSVLVESDIAPIAR( 8.45 0.61 633.0054 -0.0161 -8.5
L)
3 15.38 15.38 94.1 5.15E+05 (R)AEHPFIVEEFVLPK(F) 8.63 0.99 552.2965 -0.009 -5.4
2 15.22 15.22 90.9 3.78E+05 (R)AEHPFIVEEFVLPK(F) 8.63 1 827.9426 -0.006 -3.6
2 19.34 19.34 81.3 6.59E+04 (R)NALFCLESAWK(S) 8.65 0.97 669.8265 -0.0054 -4
3 13.22 13.22 78 1.02E+06 (K)DLFHCVSFIVPR(A) 8.87 1 497.2555 -0.0101 -6.8
2 19.96 19.96 86.8 1.01E+06 (K)DLFHCVSFIVPR(A) 8.87 1 745.3795 -0.0103 -6.9
2 16.61 11.39 81.3 1.19E+06 (R)QGIPFFGQVLLVDGK(G) 10.02 0.99 809.4494 -0.0084 -5.2
3 12.85 12.85 75.3 1.54E+04 (R)QGIPFFGQVLLVDGK(G) 10.02 0.78 539.9667 -0.0144 -8.9
4 12.21 12.21 73 6.26E+03 (R)TYIFIDEAHITEALTWLS 10.07 0.61 597.8047 -0.0265 -11.1
HK(Q)
3 15.96 7.5 85.4 5.24E+03 (R)TYIFIDEAHITEALTWLS 10.05 0.54 796.7397 -0.0189 -7.9
HK(Q)
 2 19.27 19.27 86.4 5.61E+03 (K)ELVFYYLMMAK(G) 10.17 0.99 704.3516 -0.0092 -6.5

Q5XLE4 Serum albumin 3 16.31 16.31 81.9 7.05E+04 (K)YICEHQDSISGK(L) 4.4 0.97 479.548 -0.018 -12.5 6.96%
2 19.77 19.77 96.5 1.32E+04 (K)YICEHQDSISGK(L) 4.42 0.86 718.8237 -0.0073 -5.1
2 19.48 19.48 94.1 4.09E+05 (K)EACFAEEGPK(L) 4.77 1 569.2441 -0.0072 -6.3
2 21.16 21.16 89.5 1.85E+06 (K)ADFTECCPADDK(A) 4.82 1 714.7697 -0.0085 -5.9
2 14.81 14.81 72.4 3.97E+05 (R)ATYGELADCCEK(Q) 5.12 0.99 708.7908 -0.0027 -1.9
3 18.73 18.73 97.8 7.22E+05 (K)ECCHGDLLECADDR(A) 5.35 0.97 583.8893 -0.0092 -5.2
2 24.66 24.66 90.7 6.85E+05 (K)ECCHGDLLECADDR(A) 5.35 0.97 875.3316 -0.0066 -3.8
3 22.41 13.63 94.1 1.88E+06 (K)LKPEPDAQCAAFQEDPD 5.43 0.99 686.9842 -0.0056 -2.7
K(F)
2 14.12 8.96 76.3 1.72E+06 (K)LCTVATLR(A) 5.47 1 467.2607 -0.0045 -4.8
2 15.11 3.94 85.1 1.82E+06 (K)YLYEVAR(R) 5.6 1 457.2394 -0.0063 -6.9
3 12.01 5.97 86 9.50E+05 (K)SLHTLFGDK(L) 5.97 1 339.8474 -0.0087 -8.6
2 18.92 8.97 100 1.02E+06 (K)SLHTLFGDK(L) 5.97 1 509.2685 -0.0066 -6.5
3 22.31 22.31 96.1 6.98E+05 (K)LKPEPDAQCAAFQEDPD 6.78 1 835.4062 -0.0086 -3.4
KFLGK(Y)
3 14.04 14.04 84.7 2.98E+05 (R)RHPDYSVSLLLR(I) 6.98 0.99 485.9374 -0.009 -6.2
2 14.41 10.22 78.4 1.19E+05 (R)HPDYSVSLLLR(I) 7.43 1 650.3526 -0.0076 -5.9
3 13.67 13.67 78.8 7.97E+04 (R)HPDYSVSLLLR(I) 7.43 0.97 433.9027 -0.012 -9.2
3 15.06 15.06 86.7 3.64E+05 (R)RHPYFYGPELLFHAEEY 7.73 0.98 766.0432 -0.0035 -1.5
K(A)
4 10.95 2.85 70.8 1.70E+05 (R)HPYFYGPELLFHAEEYK( 8.42 0.99 535.7562 -0.0145 -6.8
A)
3 16.31 16.31 81.3 2.01E+05 (K)CCAEADPPACYATVFDQ 9.45 0.99 1005.7732 -0.0159 -5.3
FTPLVEEPK(S)
2 21.5 21.5 95 1.14E+04 (K)CCAEADPPACYATVFDQ 9.43 0.96 1508.156 -0.0162 -5.4
FTPLVEEPK(S)
2 14.01 5.71 83.6 2.19E+06 (K)DVFLGTFLYEYSR(R) 9.8 0.98 805.3958 -0.0054 -3.3
3 14.86 7.78 88.2 4.56E+04 (K)DVFLGTFLYEYSR(R) 9.78 0.81 537.264 -0.0122 -7.6
P35747 Serum albumin 3 16.31 16.31 81.9 7.05E+04 (K)YICEHQDSISGK(L) 4.4 0.97 479.548 -0.018 -12.5 7.27%
2 19.77 19.77 96.5 1.32E+04 (K)YICEHQDSISGK(L) 4.42 0.86 718.8237 -0.0073 -5.1
2 19.48 19.48 94.1 4.09E+05 (K)EACFAEEGPK(L) 4.77 1 569.2441 -0.0072 -6.3
2 21.16 21.16 89.5 1.85E+06 (K)ADFTECCPADDK(L) 4.82 1 714.7697 -0.0085 -5.9
2 14.81 14.81 72.4 3.97E+05 (R)ATYGELADCCEK(Q) 5.12 0.99 708.7908 -0.0027 -1.9
3 18.73 18.73 97.8 7.22E+05 (K)ECCHGDLLECADDR(A) 5.35 0.97 583.8893 -0.0092 -5.2
2 24.66 24.66 90.7 6.85E+05 (K)ECCHGDLLECADDR(A) 5.35 0.97 875.3316 -0.0066 -3.8
3 22.41 13.63 94.1 1.88E+06 (K)LKPEPDAQCAAFQEDPD 5.43 0.99 686.9842 -0.0056 -2.7
K(F)
2 14.12 8.96 76.3 1.72E+06 (K)LCTVATLR(A) 5.47 1 467.2607 -0.0045 -4.8
2 15.57 15.57 73.5 1.02E+05 (K)CSSFQNFGER(A) 5.57 0.95 616.2579 -0.0075 -6.1
2 15.11 3.94 85.1 1.82E+06 (K)YLYEVAR(R) 5.6 1 457.2394 -0.0063 -6.9
3 12.01 5.97 86 9.50E+05 (K)SLHTLFGDK(L) 5.97 1 339.8474 -0.0087 -8.6
2 18.92 8.97 100 1.02E+06 (K)SLHTLFGDK(L) 5.97 1 509.2685 -0.0066 -6.5
3 22.31 22.31 96.1 6.98E+05 (K)LKPEPDAQCAAFQEDPD 6.78 1 835.4062 -0.0086 -3.4
KFLGK(Y)
4 12.15 12.15 74.8 8.13E+05 (R)RHPYFYGPELLFHAEEY 7.73 0.99 574.7834 -0.0068 -3
K(A)
3 14.04 14.04 84.7 2.98E+05 (R)RHPDYSVSLLLR(I) 6.98 0.99 485.9374 -0.009 -6.2
2 14.41 10.22 78.4 1.19E+05 (R)HPDYSVSLLLR(I) 7.43 1 650.3526 -0.0076 -5.9
3 13.67 13.67 78.8 7.97E+04 (R)HPDYSVSLLLR(I) 7.43 0.97 433.9027 -0.012 -9.2
3 15.06 15.06 86.7 3.64E+05 (R)RHPYFYGPELLFHAEEY 7.73 0.98 766.0432 -0.0035 -1.5
K(A)
4 10.95 2.85 70.8 1.70E+05 (R)HPYFYGPELLFHAEEYK( 8.42 0.99 535.7562 -0.0145 -6.8
A)
2 14.01 5.71 83.6 2.19E+06 (K)DVFLGTFLYEYSR(R) 9.8 0.98 805.3958 -0.0054 -3.3
3 14.86 7.78 88.2 4.56E+04 (K)DVFLGTFLYEYSR(R) 9.78 0.81 537.264 -0.0122 -7.6

P27425 Serotransferrin 3 18.18 18.18 88.1 1.28E+06 (K)AACVCQELHNQQASYG 5.03 0.99 655.293 -0.0105 -5.3 1.34%
K(N)
 2 23.44 23.44 87.7 4.71E+05 (K)AACVCQELHNQQASYG 5.03 0.99 982.4366 -0.009 -4.6
K(N)
3 16.63 16.63 82.4 1.22E+05 (R)LLEACTFHR(V) 5.37 0.98 382.8595 -0.0085 -7.4
2 26.5 26.5 100 1.06E+05 (K)CDEWSVNSGGNIECESA 6.57 1 1473.5889 -0.0117 -4
QSTEDCIAK(I)
2 16.23 10.57 94.2 1.76E+05 (K)SSSDPDLTWNSLK(G) 6.92 1 725.3443 -0.0043 -3
2 22.65 14.18 94.3 1.62E+05 (R)TAVPNLCQLCVGK(G) 7.12 0.98 730.3707 -0.0055 -3.7
2 19.55 12.25 93.6 2.25E+05 (K)SIVPAPPLVACVK(R) 7.68 1 675.8917 -0.0052 -3.9
2 13.48 13.48 74.8 4.69E+05 (K)GEADAMSLDGGFIYIAG 8.75 0.96 907.9306 -0.009 -5
K(C)
2 13.48 13.48 77.6 7.85E+03 (R)TAGWNIPMGLLYSEIK(H 10.25 -0.34 896.9622 -0.0131 -7.3
)

H9GZU9 Uncharacterized 2 15.91 15.91 95.4 1.62E+06 (K)ALPAPVER(T) 5.03 0.99 426.7481 -0.0049 -5.7 35.81%
protein
(Fragment)
(Immunoglobuli 2 18.16 18.16 83.4 6.61E+06 (K)VSVTCLVK(D) 6 0.93 453.2579 -0.0039 -4.4
n heavy chain)
2 18.32 18.32 84.8 2.02E+05 (K)QGESFTCGVMHEAVEN 6.23 0.99 1226.5331 -0.0067 -2.7
HYTQK(N)
3 20.89 13.51 95.7 5.63E+06 (K)DFYPPEIDVEWQSNEHPE 7.82 0.99 881.3933 -0.0028 -1.1
PEGK(Y)
3 17.2 9.81 95.5 2.49E+06 (R)VVSVLPIQHQDWLSGK(E 7.73 1 602.6679 -0.0017 -0.9
)
2 19.85 16.28 95.1 7.51E+05 (R)VVSVLPIQHQDWLSGK(E 7.73 0.99 903.4973 -0.0035 -2
)
2 23.63 16.4 97.2 9.34E+05 (K)DFYPPEIDVEWQSNEHPE 7.8 0.99 1321.587 -0.0014 -0.5
PEGK(Y)
4 15.42 15.42 92.7 4.18E+05 (K)DFYPPEIDVEWQSNEHPE 7.82 1 661.295 -0.01 -3.8
PEGK(Y)
2 17.78 17.78 91.8 9.69E+06 (K)APDVFPLTICGNTPDPK( 8 0.98 921.457 -0.0035 -1.9
V)
3 14.8 14.8 77.4 2.70E+06 (K)APDVFPLTICGNTPDPK( 8 1 614.6388 -0.0084 -4.5
V)
4 12.65 12.65 77.8 2.54E+06 (K)GDIHTFPLDLSNSAHHSL 8.08 0.93 705.841 -0.0134 -4.8
SSMMAVPR(S)
3 25.17 25.17 100 7.16E+05 (K)GDIHTFPLDLSNSAHHSL 8.08 0.94 940.786 -0.0121 -4.3
SSMMAVPR(S)
 3 22.17 22.17 100 3.39E+07 (K)VPVGCLVSNYFPEPVTV 9.53 0.95 951.1298 -0.0045 -1.6
SWNCDALK(G)
2 23.45 23.45 100 1.30E+07 (K)VPVGCLVSNYFPEPVTV 9.52 0.97 1426.1911 -0.0044 -1.6
SWNCDALK(G)
4 10.88 10.88 74.7 6.28E+06 (K)VPVGCLVSNYFPEPVTV 9.53 0.98 713.5962 -0.0164 -5.7
SWNCDALK(G)

Q95M34 Immunoglobuli 2 14.79 14.79 74.2 1.87E+05 (R)IQHQDWLSGK(E) 5.33 1 606.3111 -0.0018 -1.5 3.47%
n gamma 1
heavy chain
constant region
(Fragment)
2 14.23 14.23 87.5 6.24E+04 (K)VNNQALPQPIER(T) 5.63 0.94 689.8718 -0.0074 -5.4
2 18.16 18.16 83.4 6.61E+06 (K)VSVTCLVK(D) 6 0.93 453.2579 -0.0039 -4.4
2 21.15 21.15 84.5 2.10E+05 (K)YSTTQAQQDSDGSYFLY 6.67 0.99 1094.9857 -0.0028 -1.3
SK(L)
2 22.2 22.2 100 2.93E+05 (R)TPEVTCVVVDVSQENPD 7.23 1 1058.015 -0.0047 -2.2
VK(F)
3 16.75 16.75 88.3 2.92E+05 (R)TPEVTCVVVDVSQENPD 7.23 1 705.6779 -0.0083 -3.9
VK(F)
2 17.04 17.04 78.4 1.47E+05 (K)FNWYMDGVEVR(T) 8 0.99 708.3216 -0.0053 -3.8
2 20.32 20.32 96 1.24E+04 (K)DFYPPEINIEWQSNGQPE 8.72 0.72 1317.6163 -0.0105 -4
LETK(Y)
2 13.7 13.7 77.9 6.75E+03 (K)CPAPELLGGPSVFIFPPNP 9.48 0.73 1069.0552 -0.0119 -5.6
K(D)

H9GZU8 Uncharacterized 2 20.82 20.82 92.6 3.20E+06 (K)SQTYICNVAHPASSTK(V 5.03 1 882.4197 -0.006 -3.4 2.48%
protein )
(Fragment)
(Immunoglobuli 2 15.91 15.91 95.4 1.62E+06 (R)ALPAPVER(T) 5.03 0.99 426.7481 -0.0049 -5.7
n heavy chain)
2 22.2 22.2 100 2.93E+05 (R)TPEVTCVVVDVSQENPD 7.23 1 1058.015 -0.0047 -2.2
VK(F)
3 16.75 16.75 88.3 2.92E+05 (R)TPEVTCVVVDVSQENPD 7.23 1 705.6779 -0.0083 -3.9
VK(F)
4 14.19 2.89 75.2 1.44E+04 (K)LTVETDRWEQGESFTCV 8.28 0.97 724.09 -0.0226 -7.8
VMHEAIR(H)
2 17.91 17.91 86 1.74E+05 (R)QSSGLYSLSSMVTVPASS 8.73 0.97 1021.5236 -0.0075 -3.7
LK(S)
F6Z2L5 Uncharacterized 2 12.52 12.52 71.2 1.11E+05 (K)AHPALEDLR(Q) 5.2 0.99 511.2713 -0.0072 -7 1.95%
protein
(Apolipoprotein 2 16.28 16.28 75.6 1.85E+05 (K)KWQEEVEVYR(Q) 5.72 0.99 683.3408 -0.0054 -4
A)
3 16.53 16.53 78.7 7.33E+05 (K)LREQLGPVTQDFWDK(L) 7.43 0.99 611.3134 -0.0081 -4.4
2 20.17 20.17 95.4 1.23E+06 (K)VAPLSDEFR(E) 6.2 1 517.2677 -0.0032 -3.1
2 19.15 19.15 100 5.28E+05 (K)LREQLGPVTQDFWDK(L) 7.43 0.99 916.4672 -0.0066 -3.6
2 17.33 17.33 81.1 1.18E+06 (R)EQLGPVTQDFWDK(L) 7.63 0.99 781.8757 -0.0044 -2.8
2 16.39 9.22 85.9 5.87E+04 (R)VNLAPFSEELR(Q) 7.65 1 637.8378 -0.0056 -4.4
2 22.58 22.58 94.8 2.07E+05 (K)ASFLAAIDEASK(Q) 7.7 1 611.8175 -0.0037 -3
3 16.33 16.33 82.7 1.84E+05 (K)LREQLGPVTQDFWDKLE 7.92 0.97 734.7201 -0.0096 -4.4
K(D)

F7CSL8 Uncharacterized 2 15.47 15.47 80.6 6.45E+04 (K)QINDYVENGTQGK(I) 4.98 0.99 733.344 -0.011 -7.5 1.14%
protein
(alpha- 2 18.5 18.5 87 1.93E+05 (K)GDTHTQILEGLR(F) 6.08 0.97 670.3491 -0.0055 -4.1
antiproteinease)
2 19.24 11.09 89.5 4.36E+05 (K)LSISGCYDLK(R) 6.53 0.99 578.2863 -0.0061 -5.3
2 18.6 18.6 94.9 3.92E+05 (K)GTEAAGATIVEAIR(T) 6.97 0.99 679.8645 -0.0057 -4.2
2 17.5 17.5 93.5 6.91E+05 (R)ILPELGITK(V) 7.13 1 492.3078 -0.0052 -5.3
3 15.67 15.67 83.4 1.39E+05 (K)NLYHSEAFSINFGDIEEA 8.2 0.94 728.6763 -0.01 -4.6
K(K)
2 15.76 15.76 84.8 9.33E+03 (K)NLYHSEAFSINFGDIEEA 8.2 0.65 1092.5122 -0.0073 -3.3
K(K)
2 18.01 18.01 91.6 6.23E+05 (K)GILATFLENR(H) 8.52 1 567.3157 -0.0072 -6.4
4 12.48 5.32 74.1 1.67E+04 (R)TLLHTNVEFNRPFVLIIY 9.07 0.98 615.8345 -0.0236 -9.6
DR(N)
3 12.75 12.75 93.2 5.42E+03 (R)TLLHTNVEFNRPFVLIIY 9.07 0.59 820.7775 -0.0218 -8.9
DR(N)

B5BV12 Alpha-1- 2 15.47 15.47 80.6 6.45E+04 (K)QINDYVENGTQGK(I) 4.98 0.99 733.344 -0.011 -7.5 0.14%
antitrypsin
2 16.1 16.1 89.6 1.12E+05 (R)QADLSGITEEAPLTVSK( 7.08 0.99 879.9557 -0.0079 -4.5
A)
 3 15.67 15.67 83.4 1.39E+05 (K)NLYHSEAFSINFGDIEEA 8.2 0.94 728.6763 -0.01 -4.6
K(K)
2 15.76 15.76 84.8 9.33E+03 (K)NLYHSEAFSINFGDIEEA 8.2 0.65 1092.5122 -0.0073 -3.3
K(K)

H9GZT5 Uncharacterized 2 20.82 20.82 92.6 3.20E+06 (K)SQTYICNVAHPASSTK(V 5.03 1 882.4197 -0.006 -3.4 7.09%
protein )
(Fragment)
(Immunoglobuli 2 15.91 15.91 95.4 1.62E+06 (K)ALPAPVER(T) 5.03 0.99 426.7481 -0.0049 -5.7
n heavy chain)
2 18.16 18.16 83.4 6.61E+06 (K)VSVTCLVK(D) 6 0.93 453.2579 -0.0039 -4.4
2 14.57 14.57 80.7 1.06E+06 (R)VVSILAIQHK(D) 6.3 1 554.3453 -0.0051 -4.6
3 18.8 18.8 92.5 5.26E+05 (K)ECGGCPTCPECLSVGPSV 8.62 0.92 974.1176 -0.0118 -4
FIFPPKPK(D)
2 22.6 22.6 91.8 2.85E+06 (K)DFYPTDIDIEWK(S) 8.62 1 771.3594 -0.0043 -2.8
3 16.68 10.06 97.4 1.14E+05 (K)DFYPTDIDIEWK(S) 8.62 0.96 514.5731 -0.0111 -7.2

H9GZS9 Uncharacterized 3 15.93 15.93 90.4 7.06E+05 (K)TYICNVAHPASSTK(V) 4.78 0.99 516.9166 -0.0123 -7.9 4.21%
protein
(Fragment)
(Immunoglobuli 2 22.4 22.4 92.6 3.43E+05 (K)TYICNVAHPASSTK(V) 4.78 0.99 774.8734 -0.008 -5.2
n heavy chain)
2 18.16 18.16 83.4 6.61E+06 (K)VSVTCLVK(D) 6 0.93 453.2579 -0.0039 -4.4
3 12.91 12.91 77.9 4.27E+04 (R)VPQVYVLAPHPDELSK(N 7.12 0.89 597.9886 -0.0127 -7.1
)
3 16.28 8.01 86.8 3.81E+04 (K)DFYPTDITVEWQSNEHP 7.77 0.79 873.3931 -0.0034 -1.3
EPEGK(Y)
3 10.8 10.8 71.6 7.64E+03 (K)CPAPELLGGPSVFIFPPKP 8.98 0.87 717.7232 -0.012 -5.6
K(D)
3 16.61 13.33 85.3 1.37E+06 (R)TFPSVLQSSGLYSLSSMV 10.1 1 968.1539 -0.0283 -9.7
TVPASSLESK(T)
2 19.55 11.23 94.3 3.84E+05 (R)TFPSVLQSSGLYSLSSMV 10.1 0.97 1451.731 -0.0207 -7.1
TVPASSLESK(T)

P38029 Alpha-1- 2 16.43 16.43 79.9 3.89E+05 (K)LQHLEDTLTK(G) 5.22 0.99 599.325 -0.0047 -3.9 1.82%
antiproteinase 2
2 10.8 1.75 71.8 7.94E+04 (K)FLEDVK(K) 5.3 0.96 375.7016 -0.0073 -9.7
2 16.44 4.5 93.2 4.63E+05 (K)AVLTIDEK(G) 5.43 1 444.7529 -0.0052 -5.8
 2 12.53 1.51 89.7 7.20E+05 (K)IVDLVK(D) 5.48 1 343.7232 -0.0056 -8.1
2 16.78 8.81 93.2 1.37E+06 (K)DTVLALVNYIFFK(G) 11.9 0.99 771.9245 -0.0149 -9.7
3 17.78 9.37 89.8 1.09E+06 (K)DLDKDTVLALVNYIFFK( 11.97 0.91 672.0285 -0.0186 -9.2
G)

H9GZN9 Uncharacterized 2 19.59 19.59 91.9 3.91E+05 (R)LVCQATGFSPK(E) 5.43 0.97 604.3085 -0.0042 -3.5 0.77%
protein
(Fragment)
(Immunoglobuli 2 10.73 2.03 76.5 8.52E+04 (K)EISVSWLR(D) 7.65 1 495.2713 -0.0061 -6.2
n heavy chain)
2 18.2 18.2 92.4 6.45E+05 (K)GFSPPDVFVQWLQK(G) 10.05 0.97 824.4271 -0.006 -3.7
3 18.46 18.46 92.1 1.32E+04 (K)GFSPPDVFVQWLQK(G) 10.03 0.78 549.9507 -0.0154 -9.4
3 17.66 8.39 88.3 5.31E+05 (K)TPDLFPLVSCGPSLDESL 10.47 0.98 925.1254 -0.0283 -10.2
VAVGCLAR(D)
2 13.55 2.58 80 7.81E+04 (K)IFAIPPSFAGIFLTK(S) 10.7 0.92 811.4635 -0.0155 -9.6

A0A0B4J1 Uncharacterized 2 14.45 14.45 76.1 1.58E+05 (R)VPLTYGGQTK(I) 4.93 0.99 532.2886 -0.0083 -7.8 0.37%
C4 protein
(Immunoglobuli 2 14.22 6.41 84.6 1.96E+05 (R)IIIPVNSR(E) 6 1 456.2844 -0.0058 -6.3
n J)
3 18.41 18.41 84.9 1.74E+05 (K)FVYHLSDLCK(K) 6.55 0.98 427.8784 -0.009 -7
2 24.01 24.01 97.6 3.06E+05 (R)IIPSPENPNEDILER(H) 6.83 0.97 868.4442 -0.005 -2.9

F6V5H1 Uncharacterized 3 15.35 9.05 86.7 2.57E+05 (K)TSSFHSSLTEQDSK(D) 4.63 0.98 518.5717 -0.0073 -4.7 1.97%
protein
(Fragment)
(Immunoglobuli 2 21.49 21.49 97 1.83E+05 (K)TSSFHSSLTEQDSK(D) 4.63 0.96 777.3513 -0.0125 -8
n light chain)
2 23.01 23.01 93.7 3.74E+05 (K)ADYEAHNVYACEVSHK( 4.88 0.99 946.9098 -0.0109 -5.7
T)
2 11.44 11.44 74.5 2.40E+06 (K)TLSSPLVK(S) 5.55 1 422.7573 -0.0065 -7.7
2 13.71 13.71 80.6 1.22E+06 (K)DNTYSLSSTLTLPK(A) 7.57 0.99 770.3967 -0.004 -2.6

A0A0A1E3 Immmunoglobu 2 15.76 15.76 80.3 1.01E+05 (K)GNGAAISQGVQTTKPSK( 4.4 0.91 822.4301 -0.0182 -11.1 3.59%
W4 lin lambda light Q)
chain variable
 region
(Fragment)

3 14.3 9.42 74.5 8.87E+05 (K)SYSSVSCQVTHQGK(T) 4.5 1 523.2401 -0.0112 -7.1

2 21.56 21.56 88.1 4.06E+05 (K)SYSSVSCQVTHQGK(T) 4.5 0.99 784.3569 -0.0104 -6.6
3 13.86 13.86 72.1 6.66E+06 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3726 -0.0126 -5.7
WK(G)
2 21.42 16.47 100 5.09E+04 (K)ATVVCLISDFSPSDLTVS 10.08 0.98 1113.0569 -0.0093 -4.2
WK(G)

A0A0A1E4 Immmunoglobu 2 11.51 5.73 71.8 5.78E+04 (K)SYSSVSCQVK(H) 4.47 0.99 572.7643 -0.009 -7.8 0.15%
70 lin lambda light
chain variable
region
(Fragment)
2 16.64 16.64 85.8 1.13E+05 (K)VGWFQQIPGTAPK(T) 7.7 0.98 714.8826 -0.0055 -3.8
2 18 18 95.1 1.77E+05 (K)ATVVCLISDFSPSGLEVI 10.73 1 1111.075 -0.0146 -6.6
WK(V)

A0A0A1E6 Immmunoglobu 2 18.39 18.39 88.4 1.54E+05 (R)LTIAGGPTSTPSVSLFPPS 8.38 0.9 1344.1868 -0.0111 -4.1 3.04%
I1 lin lambda light SEELSANK(A)
chain variable
region
(Fragment)
3 13.86 13.86 72.1 6.66E+06 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3726 -0.0126 -5.7
WK(V)
2 21.42 16.47 100 5.09E+04 (K)ATVVCLISDFSPSDLTVS 10.08 0.98 1113.0569 -0.0093 -4.2
WK(V)

A0A0A1E3 Immmunoglobu 3 16.81 16.81 79.6 9.61E+05 (K)VNGAAISQGVQTTKPSK( 4.63 0.97 562.6419 -0.0069 -4.1 3.40%
Y7 lin lambda light Q)
chain variable
region
(Fragment)
3 13.86 13.86 72.1 6.66E+06 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3726 -0.0126 -5.7
WK(V)
2 21.42 16.47 100 5.09E+04 (K)ATVVCLISDFSPSDLTVS 10.08 0.98 1113.0569 -0.0093 -4.2
WK(V)
A0A0A1E6 Immmunoglobu 2 14 14 77.6 5.24E+04 (K)YAASSYLPLTPTQWK(S) 8.2 0.89 863.4462 0.0005 0.3 3.00%
A8 lin lambda light
chain variable
region
(Fragment)
3 13.86 13.86 72.1 6.66E+06 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3726 -0.0126 -5.7
WK(V)
2 21.42 16.47 100 5.09E+04 (K)ATVVCLISDFSPSDLTVS 10.08 0.98 1113.0569 -0.0093 -4.2
WK(V)

H9GZV1 Uncharacterized 3 13.49 13.49 81.4 5.82E+04 (R)LSGKPTHVNVSVVMAEA 7.02 0.99 779.0354 -0.014 -6 0.63%
protein DGTCY(-)
(Fragment)
(Immunoglobuli 2 12.07 12.07 74.7 9.05E+05 (R)EPGQSVPTFAVTSLLR(V) 9.02 0.97 851.4558 -0.0127 -7.5
n heavy chain)
3 15.24 15.24 86.5 1.32E+05 (R)EPGQSVPTFAVTSLLR(V) 9.02 0.92 567.9727 -0.0135 -7.9
2 20.06 20.06 95.7 3.21E+05 (K)GFFPLGFPEPVK(V) 9.47 0.96 667.8556 -0.0104 -7.8

Q7SIH1 Alpha-2- 2 13.82 4.66 86.6 8.64E+04 (R)DLKPAIVK(V) 5.07 1 442.2803 -0.0078 -8.8 0.80%
macroglobulin
2 18.6 10.33 90.5 7.82E+05 (R)VTASPQSLCALR(A) 6.12 1 651.8448 -0.0011 -0.9
3 12.77 6.67 87 5.41E+05 (K)DTIIKPLLVEPEGLEK(E) 7.92 0.98 598.6772 -0.0088 -4.9
2 12.11 4.93 75.4 3.91E+05 (K)DTIIKPLLVEPEGLEK(E) 7.92 0.99 897.5142 -0.0048 -2.7

P0DM92 Apolipoprotein 2 17.09 9.54 84.8 2.54E+05 (R)EYVAQFEASALGK(Q) 7.07 1 706.8537 -0.0055 -3.9 0.44%
A-I (Fragment)
4 10.85 4.6 80.2 1.63E+05 (K)LREQIGPVTQEFWDNLE 7.92 0.97 551.2895 0.0172 7.8
K(E)
3 10.7 0 79.3 4.06E+05 (R)EQIGPVTQEFWDNLEK(E 8.27 0.97 644.9918 0.0271 14
)
2 15.9 6.78 74.7 1.60E+05 (R)EQIGPVTQEFWDNLEK(E 8.27 0.97 966.9854 0.0297 15.4
)

P0DMA9 Apolipoprotein 3 10.7 0 79.3 4.06E+05 (R)EQLGPVTQEFWDNLEK( 8.27 0.97 644.9918 0.0271 14 1.09%
A-I E)
2 15.9 6.78 74.7 1.60E+05 (R)EQLGPVTQEFWDNLEK( 8.27 0.97 966.9854 0.0297 15.4
E)
2 11.67 11.67 70.7 1.91E+06 (R)QGLLPVLESLK(V) 9.15 1 598.8628 -0.0066 -5.5
F6XWM5 Uncharacterized 2 17.43 17.43 91.9 7.79E+05 (K)YVTLPVADQDTCVK(H) 6.63 1 804.898 -0.0051 -3.1 1.99%
protein
(Fragment)
(Haptoglobulin) 2 19.58 19.58 94.6 3.70E+06 (K)VPSILDWVQK(T) 8.85 1 592.8339 -0.0069 -5.8

F6R3F4 Uncharacterized 2 18.57 18.57 94.5 1.67E+05 (R)LGVYELLLK(V) 8.78 1 524.3219 -0.0083 -8 0.08%
protein
(Fragment)
(Inter-alpha- 2 16.66 16.66 83.8 1.93E+04 (K)VTFELVYEELLK(R) 9.92 0.99 741.903 -0.0103 -6.9
trypsin inhibitor
heavy chain)

F6RUZ6 Fibrinogen 2 18.46 18.46 85.1 1.64E+05 (K)GLIDEVNQDFTNR(I) 7.42 0.99 760.8676 -0.006 -4 0.10%
alpha chain
2 16.12 16.12 75.8 7.12E+04 (K)ETDWPFCSDEDWNYK(C 8.25 0.97 996.3863 -0.0099 -5
)

P32262 Antithrombin- 2 17.55 11.45 85.9 5.00E+04 (R)DIPVNPMCIYR(S) 7.68 0.97 689.3329 -0.0068 -5 0.05%
III
2 15.69 9.13 77.8 5.73E+04 (R)VAEGTQVLELPFK(G) 7.97 0.92 715.8933 -0.0096 -6.7

F6W2Y1 Uncharacterized 2 14.86 14.86 79.9 1.33E+05 (R)DNCCILDER(F) 5.55 0.98 597.7437 -0.0077 -6.4 0.12%
protein
(Fibrinogen 2 17.89 17.89 86.1 7.21E+04 (K)DLQDFEDILHR(A) 8.08 0.96 700.8425 -0.0027 -2
gamma chain)
3 14.38 9.51 76 5.72E+04 (K)DLQDFEDILHR(A) 8.08 0.95 467.5619 -0.0093 -6.7

100.00%
Peak 3
Database Protein Name z Score Fwd- SPI Spectral Sequence RT Average m/z Measured MH+ Mass MH+ Error Mean
Accession Rev (%) Intensity (min) Chi (Da) Shift (Da) (ppm) Spectral
Score Squated (protein % in
a fraction)

P35747 Serum albumin 3 16.17 16.17 84.6 1.00E+06 (K)YICEHQDSISGK(L) 4.43 0.99 479.5497 -0.0129 -9 2.52%
2 24.76 24.76 96.9 2.11E+05 (K)YICEHQDSISGK(L) 4.43 0.99 718.8218 -0.0111 -7.7
2 19.62 19.62 88.1 6.01E+05 (K)ADFTECCPADDK(L) 4.92 0.99 714.77 -0.0079 -5.5
2 14.08 14.08 80.3 5.58E+04 (K)EACFAEEGPK(L) 4.85 1 569.2445 -0.0064 -5.6
2 16.36 16.36 79.2 1.04E+05 (R)ATYGELADCCEK(Q) 5.27 0.99 708.787 -0.0103 -7.2
3 18.07 18.07 95.4 4.96E+05 (K)ECCHGDLLECADDR(A) 5.48 0.98 583.8879 -0.0134 -7.6
2 23.36 23.36 90.4 2.77E+05 (K)ECCHGDLLECADDR(A) 5.48 0.98 875.33 -0.0098 -5.6
3 20.78 12.32 85.2 3.19E+05 (K)LKPEPDAQCAAFQEDPD 5.57 0.97 686.9826 -0.0104 -5.1
K(F)
2 12.09 4.04 75.5 6.85E+05 (K)LCTVATLR(A) 5.6 1 467.2584 -0.0091 -9.7
2 12.65 4.91 81.1 6.84E+05 (K)YLYEVAR(R) 5.78 1 457.2384 -0.0083 -9.1
3 12.2 5.94 89.1 4.45E+05 (K)SLHTLFGDK(L) 6.25 1 339.8468 -0.0105 -10.3
2 16.59 6.51 87.1 3.43E+05 (K)SLHTLFGDK(L) 6.25 0.99 509.2677 -0.0082 -8.1
3 19.36 19.36 89.4 3.10E+05 (K)LKPEPDAQCAAFQEDPD 6.88 1 835.4048 -0.0128 -5.1
KFLGK(Y)
3 13.04 13.04 79.7 8.97E+04 (R)RHPDYSVSLLLR(I) 7.12 0.96 485.9372 -0.0096 -6.6
 4 11.92 11.92 76.5 4.78E+05 (R)RHPYFYGPELLFHAEEY 7.87 0.99 574.782 -0.0124 -5.4
K(A)
2 16.99 8.9 86.8 2.25E+05 (K)DVFLGTFLYEYSR(R) 9.82 0.87 805.393 -0.011 -6.8

F6RI47 Uncharacterized 2 15.3 15.3 73.6 7.17E+04 (K)FSQQLNNQGCLSQQVK( 5.67 0.91 939.9528 -0.0143 -7.6 0.76%
protein T)
(Alpha-2- 2 10.55 2.68 71.1 1.57E+05 (R)IAQWQNLK(L) 6.03 0.99 500.7787 -0.0073 -7.3
macroglobulin-
like protein)
3 14.46 6.22 89.8 6.29E+04 (K)ESLVFVQTDKPIYKPGQT 6.73 0.98 759.7502 -0.0129 -5.6
VK(F)
3 17.98 9.96 93.5 2.74E+05 (K)VDLSFSPAQSLPGSPAHL 7.57 0.98 660.3452 -0.0135 -6.8
R(V)
2 17.88 17.88 80.1 2.76E+04 (K)VDLSFSPAQSLPGSPAHL 7.57 0.95 990.0146 -0.0126 -6.4
R(V)
2 12.66 5.1 74 4.80E+04 (K)DIYSFLK(D) 7.97 1 443.2357 -0.0075 -8.5
2 13.47 13.47 72.8 7.52E+03 (K)AGALCLSSGAGLGLSPT 7.97 0.67 980.0127 -0.0147 -7.5
ASLR(A)
2 18.55 14.02 97.7 9.39E+04 (R)VSVNLEESPAFLAVPGEK 8.33 0.9 943.4937 -0.0104 -5.5
(E)
2 14.52 14.52 82.8 1.62E+05 (K)QLTFPLSSEPFQGSYK(V) 8.38 0.96 914.9555 -0.0079 -4.3
3 11.63 11.63 73.2 6.96E+04 (R)ELPCGQTQTVQVHYILN 8.47 0.93 965.8322 -0.0213 -7.3
GQVLQELK(E)
3 15.93 15.93 82.4 5.13E+04 (R)LLVYTILPDGEVVGDSA 8.53 0.87 630.3411 -0.0179 -9.5
K(Y)
3 15.4 15.4 95 1.11E+05 (R)AEHPFIVEEFVLPK(F) 8.7 0.98 552.2961 -0.0102 -6.1
2 14.95 10.22 89.6 6.99E+04 (R)AEHPFIVEEFVLPK(F) 8.7 0.98 827.9423 -0.0066 -4
3 11.92 11.92 83.3 1.77E+05 (K)DLFHCVSFIVPR(A) 8.88 1 497.2557 -0.0095 -6.4
2 20.19 20.19 93.7 1.54E+05 (K)DLFHCVSFIVPR(A) 8.88 1 745.3811 -0.0071 -4.8
2 17.34 13.79 90.2 3.88E+05 (R)QGIPFFGQVLLVDGK(G) 10.03 0.95 809.4498 -0.0076 -4.7

H9GZT5 Uncharacterized 2 20.27 20.27 91.9 2.74E+06 (K)SQTYICNVAHPASSTK(V 5.15 0.99 882.4179 -0.0096 -5.4 2.85%
protein )
(Fragment)
2 16.38 16.38 94.9 7.94E+05 (K)ALPAPVER(T) 5.15 1 426.7465 -0.0081 -9.4
2 18.2 10.51 83.8 1.88E+06 (K)VSVTCLVK(D) 6.2 0.99 453.2569 -0.0059 -6.6
 3 18.02 18.02 81.1 1.01E+05 (R)EPQVYVLAPHRDELSK(N 6.2 0.99 627.6623 -0.0141 -7.5
)
2 13.48 13.48 78.4 3.16E+05 (R)VVSILAIQHK(D) 6.58 1 554.343 -0.0097 -8.8
2 21.81 21.81 87.7 6.42E+05 (K)YSTTPAQLDSDGSYFLYS 7.65 1 1071.9933 -0.0073 -3.4
K(L)
3 17.14 17.14 84.9 1.51E+05 (K)ECGGCPTCPECLSVGPSV 8.62 0.94 974.115 -0.0196 -6.7
FIFPPKPK(D)
2 22.69 22.69 93.8 5.51E+05 (K)DFYPTDIDIEWK(S) 8.65 1 771.3591 -0.0049 -3.2
3 12.82 9.28 81.1 1.42E+04 (K)DFYPTDIDIEWK(S) 7.67 0.11 514.5733 -0.0105 -6.8

H9GZU8 Uncharacterized 2 20.27 20.27 91.9 2.74E+06 (K)SQTYICNVAHPASSTK(V 5.15 0.99 882.4179 -0.0096 -5.4 1.48%
protein )
(Fragment)
(Immunoglobuli 2 16.38 16.38 94.9 7.94E+05 (R)ALPAPVER(T) 5.15 1 426.7465 -0.0081 -9.4
n heavy chain)
2 18.41 18.41 88.4 2.87E+04 (R)TPEVTCVVVDVSQENPD 7.32 0.96 1058.0114 -0.0119 -5.6
VK(F)
3 11.78 7.19 75.7 4.39E+04 (R)TPEVTCVVVDVSQENPD 7.32 0.92 705.6754 -0.0158 -7.5
VK(F)
2 17.5 17.5 85.6 1.15E+05 (R)QSSGLYSLSSMVTVPASS 8.75 1 1021.5249 -0.0049 -2.4
LK(S)

H9GZQ9 Uncharacterized 2 18.2 10.51 83.8 1.88E+06 (K)VSVTCLVK(D) 6.2 0.99 453.2569 -0.0059 -6.6 0.78%
protein
(Fragment)
(Immunoglobuli 2 19.85 19.85 86.8 7.86E+03 (K)YSTTQAQQDSDGSYFLY 6.73 0.64 1094.9818 -0.0106 -4.8
n heavy chain) SK(L)
2 18.41 18.41 88.4 2.87E+04 (R)TPEVTCVVVDVSQENPD 7.32 0.96 1058.0114 -0.0119 -5.6
VK(F)
3 11.78 7.19 75.7 4.39E+04 (R)TPEVTCVVVDVSQENPD 7.32 0.92 705.6754 -0.0158 -7.5
VK(F)

H9GZU9 Uncharacterized 2 16.38 16.38 94.9 7.94E+05 (K)ALPAPVER(T) 5.15 1 426.7465 -0.0081 -9.4 34.53%
protein
(Fragment)
(Immunoglobuli 2 18.2 10.51 83.8 1.88E+06 (K)VSVTCLVK(D) 6.2 0.99 453.2569 -0.0059 -6.6
n heavy chain)
3 17.22 10.03 95.8 1.06E+06 (R)VVSVLPIQHQDWLSGK(E 7.87 0.99 602.6658 -0.008 -4.4
)
 3 20.28 12.97 94 7.53E+05 (K)DFYPPEIDVEWQSNEHPE 7.88 0.99 881.3917 -0.0076 -2.9
PEGK(Y)
2 20.29 13.7 94.3 9.97E+04 (K)DFYPPEIDVEWQSNEHPE 7.87 0.94 1321.5829 -0.0096 -3.6
PEGK(Y)
2 19.27 19.27 91.7 1.05E+07 (K)APDVFPLTICGNTPDPK( 8.05 0.95 921.4582 -0.0011 -0.6
V)
3 15.06 15.06 77.8 3.64E+06 (K)APDVFPLTICGNTPDPK( 8.05 1 614.639 -0.0078 -4.2
V)
4 11.03 11.03 76.3 2.01E+06 (K)GDIHTFPLDLSNSAHHSL 8.13 0.9 705.8406 -0.015 -5.3
SSMMAVPR(S)
3 24.17 24.17 100 4.49E+05 (K)GDIHTFPLDLSNSAHHSL 8.13 0.95 940.7865 -0.0106 -3.8
SSMMAVPR(S)
3 18.41 18.41 96.9 4.21E+07 (K)VPVGCLVSNYFPEPVTV 9.55 0.95 951.1305 -0.0024 -0.8
SWNCDALK(G)
2 23.45 23.45 100 2.02E+07 (K)VPVGCLVSNYFPEPVTV 9.55 0.96 1426.1931 -0.0004 -0.1
SWNCDALK(G)
4 15.53 10.08 87.4 5.28E+06 (K)VPVGCLVSNYFPEPVTV 9.55 0.98 713.5972 -0.0124 -4.3
SWNCDALK(G)

F6Z2L5 Uncharacterized 2 16.54 16.54 82.4 5.02E+04 (K)KWQEEVEVYR(Q) 5.92 1 683.3421 -0.0028 -2.1 0.79%
protein
(Apoliproprotei 2 20.49 20.49 96.8 7.40E+05 (K)VAPLSDEFR(E) 6.42 0.99 517.2649 -0.0088 -8.5
n A1)
3 16.6 16.6 83.8 1.58E+05 (K)LREQLGPVTQDFWDK(L) 7.55 0.99 611.3124 -0.0111 -6
2 17.3 17.3 96.1 6.50E+04 (K)LREQLGPVTQDFWDK(L) 7.55 0.98 916.4641 -0.0128 -7
2 17.25 17.25 81.9 3.26E+05 (R)EQLGPVTQDFWDK(L) 7.73 0.99 781.8743 -0.0072 -4.6
2 20.69 20.69 90.5 1.38E+05 (K)ASFLAAIDEASK(Q) 7.83 1 611.8162 -0.0063 -5.1
2 22 22 93.3 5.18E+05 (K)LLDNWDSLGTTLGK(L) 8.28 0.99 766.8979 -0.007 -4.6

H9GZS9 Uncharacterized 3 15.94 15.94 90.6 4.33E+06 (K)TYICNVAHPASSTK(V) 4.88 0.99 516.9169 -0.0114 -7.3 4.61%
protein
(Fragment)
(Immunoglobuli 2 25.51 25.51 94.4 1.82E+06 (K)TYICNVAHPASSTK(V) 4.88 0.99 774.8728 -0.0092 -5.9
n heavy chain)
2 11.51 11.51 73.1 3.46E+04 (K)VNNQALPAPVER(T) 5.48 0.98 654.3511 -0.0117 -8.9
2 18.2 10.51 83.8 1.88E+06 (K)VSVTCLVK(D) 6.2 0.99 453.2569 -0.0059 -6.6
2 13.02 13.02 75.1 2.31E+05 (K)DSDGSYFLYSK(L) 6.75 0.99 641.2849 -0.0009 -0.7
 3 14.48 9.33 84 7.85E+03 (R)TFPSVLQSSGLYSLSSmV 9.2 0.71 973.4915 15.9845 -3.6
TVPASSLESK(T)
3 13.16 13.16 70.8 1.08E+05 (R)TFPSVLQSSGLYSLSSMV 10.02 0.98 968.1612 -0.0064 -2.2
TVPASSLESK(T)
2 23.67 14.54 98.7 2.62E+06 (R)TFPSVLQSSGLYSLSSMV 10.1 0.99 1451.7391 -0.0045 -1.5
TVPASSLESK(T)
4 14.04 14.04 81.9 5.78E+05 (R)TFPSVLQSSGLYSLSSMV 10.1 1 726.3716 -0.0108 -3.7
TVPASSLESK(T)

O75882 Attractin 2 17.46 17.46 80.1 8.69E+04 (K)GDECQLCEVENR(Y) 5.28 0.93 754.804 -0.0097 -6.4 0.09%
2 18.52 12.78 84.8 2.19E+04 (R)SEAACLAAGPGIR(C) 6.13 1 636.8187 -0.0064 -5
2 16.8 16.8 86.2 1.05E+04 (R)LTGSSGFVTDGPGNYK(Y 6.05 0.81 800.3828 -0.0066 -4.1
)
2 19.61 12.08 90.3 6.42E+03 (K)LTLTPWVGLR(K) 8.83 0.75 578.3438 -0.0081 -7
3 14 14 76.2 1.12E+05 (R)NQECIALPENICGIGWHL 8.98 0.86 961.464 0.0028 1
VGNSCLK(I)

P27425 Serotransferrin 3 15.66 15.66 84.1 3.44E+05 (K)AACVCQELHNQQASYG 5.15 0.98 655.2916 -0.0147 -7.5 0.23%
K(N)
2 22.46 22.46 87 7.14E+04 (K)AACVCQELHNQQASYG 5.15 0.98 982.434 -0.0142 -7.2
K(N)
3 20.05 20.05 84.5 4.95E+04 (K)CDEWSVNSGGNIECESA 6.65 0.85 982.7276 -0.014 -4.8
QSTEDCIAK(I)
2 24.04 24.04 84.9 2.40E+04 (K)CDEWSVNSGGNIECESA 6.65 0.98 1473.5883 -0.0129 -4.4
QSTEDCIAK(I)
2 13.39 6.09 78.2 2.47E+04 (K)SIVPAPPLVACVK(R) 7.8 0.9 675.8895 -0.0096 -7.1
2 13.48 13.48 83.8 5.73E+04 (K)GEADAMSLDGGFIYIAG 8.63 0.92 907.9341 -0.002 -1.1
K(C)

A0A0A1E3 Immmunoglobu 3 12.58 8.49 80.5 8.91E+05 (K)GNGAAISQGVQTTKPSK( 4.43 0.96 548.6227 -0.0176 -10.7 10.21%
V9 lin lambda light Q)
chain variable
region
(Fragment)
2 15.68 15.68 86 1.57E+05 (K)GNGAAISQGVQTTKPSK( 4.43 0.89 822.4317 -0.015 -9.1
Q)
3 14.32 9.26 75 1.30E+06 (K)SYSSVSCQVTHQGK(T) 4.55 0.99 523.2401 -0.0112 -7.1
2 20.46 20.46 85.5 4.20E+05 (K)SYSSVSCQVTHQGK(T) 4.55 0.99 784.357 -0.0102 -6.5
 2 16.76 16.76 84.9 7.44E+03 (K)LTQPSSVSVALGQTATIT 7.2 0.67 1031.5394 -0.0134 -6.5
CK(G)
2 20.19 15.43 97.3 8.21E+06 (K)ATVVCLISDFSPSDLTVS 10.17 1 1113.0571 -0.0089 -4
WK(G)
3 16.72 16.72 86.8 1.47E+07 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3732 -0.0108 -4.9
WK(G)

A0A0A1E6 Immmunoglobu 3 17.22 17.22 78.4 1.51E+06 (K)VNGAAISQGVQTTKPSK( 4.72 0.99 562.6407 -0.0105 -6.2 9.73%
P5 lin lambda light Q)
chain variable
region
(Fragment)
2 13.82 8.73 80.2 7.86E+03 (R)LSVLGGPTSAPSVSLFPPS 8.75 0.73 1336.1911 -0.0076 -2.8
SEELSANK(A)
3 15.54 7.77 86 2.36E+04 (R)LSVLGGPTSAPSVSLFPPS 8.8 0.88 891.13 -0.0071 -2.6
SEELSANK(A)
2 20.19 15.43 97.3 8.21E+06 (K)ATVVCLISDFSPSDLTVS 10.17 1 1113.0571 -0.0089 -4
WK(V)
3 16.72 16.72 86.8 1.47E+07 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3732 -0.0108 -4.9
WK(V)

A0A0A1E9 Immmunoglobu 2 16.76 16.76 84.9 7.44E+03 (K)LTQPSSVSVALGQTATIT 7.2 0.67 1031.5394 -0.0134 -6.5 9.14%
27 lin lambda light CK(G)
chain variable
region
(Fragment)
2 15.42 15.42 87.6 8.13E+04 (K)YAASSYLPLTPTQWK(S) 8.28 0.95 863.4455 -0.0009 -0.5
2 20.19 15.43 97.3 8.21E+06 (K)ATVVCLISDFSPSDLTVS 10.17 1 1113.0571 -0.0089 -4
WK(V)
3 16.72 16.72 86.8 1.47E+07 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3732 -0.0108 -4.9
WK(V)

A0A0A1E4 Immmunoglobu 3 13.1 9.3 79.7 8.01E+05 (K)DSERPSGIPDR(F) 4.47 0.97 410.198 -0.0122 -9.9 3.65%
17 lin lambda light
chain variable
region
(Fragment)
2 14.27 6.93 88.6 1.75E+05 (K)DSERPSGIPDR(F) 4.47 0.98 614.7903 -0.0183 -14.9
2 15.49 9.42 79.8 1.06E+06 (K)SYSSVSCQVK(H) 4.5 0.99 572.7648 -0.008 -7
 2 22.17 22.17 100 7.15E+06 (K)ATVVCLISDFSPSGLEVI 10.82 1 1111.0763 -0.012 -5.4
WK(V)

A0A0A1E6 Immmunoglobu 2 15.49 9.42 79.8 1.06E+06 (K)SYSSVSCQVK(H) 4.5 0.99 572.7648 -0.008 -7 3.27%
K2 lin lambda light
chain variable
region
(Fragment)
3 10.45 10.45 81.2 3.48E+04 (K)TLIYDDTKR(A) 4.92 0.87 375.5328 -0.0108 -9.6
2 22.17 22.17 100 7.15E+06 (K)ATVVCLISDFSPSGLEVI 10.82 1 1111.0763 -0.012 -5.4
WK(V)

A0A0A1E6 Immmunoglobu 3 13.55 8.68 81.9 7.92E+05 (R)LTIAGGPTSTPSVSLFPPS 8.43 0.96 896.4595 -0.0135 -5 9.58%
I1 lin lambda light SEELSANK(A)
chain variable
region
(Fragment)
2 14.41 14.41 87.9 3.86E+05 (R)LTIAGGPTSTPSVSLFPPS 8.43 0.94 1344.1857 -0.0133 -4.9
SEELSANK(A)
2 20.19 15.43 97.3 8.21E+06 (K)ATVVCLISDFSPSDLTVS 10.17 1 1113.0571 -0.0089 -4
WK(V)
3 16.72 16.72 86.8 1.47E+07 (K)ATVVCLISDFSPSDLTVS 10.18 1 742.3732 -0.0108 -4.9
WK(V)

F6V5H1 Uncharacterized 3 17.6 11.56 87.5 1.06E+06 (K)TSSFHSSLTEQDSK(D) 4.72 0.99 518.5707 -0.0103 -6.6 2.76%
protein
(Fragment)
(Immunoglobuli 2 22.24 22.24 96.1 4.84E+05 (K)TSSFHSSLTEQDSK(D) 4.72 0.97 777.3527 -0.0097 -6.2
n light chain)
3 17.52 17.52 74.9 1.15E+06 (K)ADYEAHNVYACEVSHK( 5 1 631.609 -0.0107 -5.7
T)
2 24 24 93.7 2.15E+05 (K)ADYEAHNVYACEVSHK( 4.98 0.99 946.9101 -0.0103 -5.4
T)
2 11.01 11.01 75.3 2.36E+06 (K)TLSSPLVK(S) 5.7 1 422.7573 -0.0065 -7.7
2 14.01 14.01 82.3 1.69E+06 (K)DNTYSLSSTLTLPK(A) 7.65 0.99 770.3953 -0.0068 -4.4

F6W2Y1 Uncharacterized 2 15.44 15.44 81.1 3.95E+05 (R)DNCCILDER(F) 5.65 0.98 597.7428 -0.0095 -7.9 0.35%
protein
 (Fibrinogen 3 15.09 11.19 79.1 1.71E+05 (K)DLQDFEDILHR(A) 8.15 0.98 467.5619 -0.0093 -6.7
gamma chain)
2 20.31 15.13 91.6 1.48E+05 (K)DLQDFEDILHR(A) 8.15 0.98 700.8369 -0.0139 -10
3 18.17 18.17 80.8 1.08E+05 (R)FGSYCPTTCGIADFLSNY 9.17 0.97 911.069 -0.009 -3.3
QTSVDK(D)
2 26.97 26.97 92 5.31E+04 (R)FGSYCPTTCGIADFLSNY 9.18 0.89 1366.1011 -0.0065 -2.4
QTSVDK(D)

P0DM92 Apolipoprotein 2 16.67 16.67 70.9 1.37E+06 (K)VQPYLDDFQK(K) 6.65 1 626.8106 -0.0069 -5.5 0.66%
A-I (Fragment)
2 17.15 10.69 85.9 8.97E+04 (R)EYVAQFEASALGK(Q) 7.15 0.99 706.8524 -0.0081 -5.7
3 11.9 3.77 74.2 1.22E+05 (K)LREQIGPVTQEFWDNLE 8 0.99 734.7193 0.0244 11.1
K(E)
2 16.09 7.3 75.7 7.70E+04 (R)EQIGPVTQEFWDNLEK(E 8.33 0.93 966.9836 0.0261 13.5
)

P0DMA9 Apolipoprotein 2 16.09 7.3 75.7 7.70E+04 (R)EQLGPVTQEFWDNLEK( 8.33 0.93 966.9836 0.0261 13.5 0.36%
A-I E)
2 12.84 12.84 74 8.32E+05 (R)QGLLPVLESLK(V) 9.2 1 598.8636 -0.005 -4.2

P38029 Alpha-1- 2 10.75 10.75 72.4 6.39E+04 (K)QINDYVEK(G) 4.82 0.87 504.7488 -0.0093 -9.2 0.43%
antiproteinase 2
2 14.72 3.73 87.7 2.21E+05 (K)AVLTIDEK(G) 5.6 1 444.7515 -0.008 -8.9
2 16.51 9.97 87.5 3.50E+05 (K)DTVLALVNYIFFK(G) 11.88 0.92 771.9249 -0.0141 -9.2
3 17.95 10.13 92.2 4.32E+05 (K)DLDKDTVLALVNYIFFK( 11.98 0.88 672.0297 -0.015 -7.5
G)

F6XWM5 Uncharacterized 3 19.3 19.3 97.8 8.56E+04 (K)LPECEAVCGKPK(N) 4.67 0.97 463.2238 -0.014 -10.1 0.29%
protein (Fragm
(Haptoglobulin) 2 12.54 12.54 75.6 1.48E+04 (K)LPECEAVCGKPK(N) 4.67 0.99 694.332 -0.0141 -10.2
2 14.69 14.69 86.7 1.66E+05 (K)YVTLPVADQDTCVK(H) 6.73 0.99 804.8965 -0.0081 -5
2 14.89 14.89 81.9 4.55E+05 (K)VPSILDWVQK(T) 8.88 1 592.8344 -0.0059 -4.9

P04937 Fibronectin 3 17.26 7.91 90.2 5.90E+04 (K)LGVRPSQGGEAPR(E) 4.42 0.99 441.9036 -0.0165 -12.5 0.14%
3 12.82 6.74 81.2 4.94E+04 (R)VDVLPVNLPGEHGQR(L) 7.23 0.92 543.9574 -0.0131 -8
 2 15.92 5.54 86.2 2.23E+05 (R)VTWAPPPSIELTNLLVR( 10.07 0.94 953.5396 -0.0077 -4.1
Y)
3 18.32 18.32 85.8 8.76E+03 (R)VTWAPPPSIELTNLLVR( 10.07 0.91 636.0256 -0.0174 -9.1
Y)

F7CYR1 Uncharacterized 3 10.15 5.97 73.9 3.44E+04 (K)ATEDEGSEQKIPEATNR( 4.53 0.86 625.6245 -0.0137 -7.3 0.03%
protein R)
(Anti-thrombin 2 18.26 18.26 91.7 3.77E+04 (R)DIPVNPMCIYR(S) 7.78 1 689.332 -0.0086 -6.3
III)
3 19.4 10.18 100 5.17E+03 (R)ITDVIPHGAINELTVLVL 11.73 0.65 928.1882 -0.0253 -9.1
VNTIYFK(G)

F7CYP1 Uncharacterized 2 11.71 11.71 70.8 2.13E+05 (K)LSISGCYDLK(R) 6.63 0.98 578.2861 -0.0065 -5.6 0.25%
protein
(Alpha-1- 2 16.65 9.2 96.1 1.21E+05 (K)GTEAAGATIVEAIR(T) 7.07 0.98 679.8623 -0.0101 -7.4
antiproteinase-
like 2-like
isoform)
2 15.44 15.44 90.8 3.01E+05 (R)ILPELGITK(V) 7.25 1 492.3067 -0.0074 -7.6

H9GZN9 Uncharacterized 2 16.61 16.61 91.8 7.67E+04 (R)LVCQATGFSPK(E) 5.57 0.99 604.3054 -0.0104 -8.7 0.05%
protein
(Fragment)
(Immunoglobuli 2 13.4 4.66 78.7 2.75E+04 (K)EISVSWLR(D) 7.77 0.92 495.2693 -0.0101 -10.2
n heavy chain)
2 10.47 0.01 77.6 2.29E+04 (K)IFAIPPSFAGIFLTK(S) 10.68 0.8 811.4648 -0.0129 -8

A0A0B4J1 Uncharacterized 3 16.73 16.73 82.7 6.23E+04 (K)FVYHLSDLCK(K) 6.67 0.98 427.8771 -0.0129 -10 0.03%
C4 protein
(Immunoglobuli 2 18.87 18.87 94 1.51E+04 (R)IIPSPENPNEDILER(H) 6.93 0.98 868.4408 -0.0118 -6.8
n J chain)

Q7SIH1 Alpha-2- 2 19.4 12.33 92.9 1.95E+05 (R)VTASPQSLCALR(A) 6.27 1 651.8417 -0.0073 -5.6 0.16%
macroglobulin
3 14.9 6.16 86.3 1.42E+05 (K)DTIIKPLLVEPEGLEK(E) 7.98 0.95 598.6765 -0.0109 -6.1
2 11.39 5.28 79.9 7.21E+04 (K)DTIIKPLLVEPEGLEK(E) 7.98 0.9 897.5124 -0.0084 -4.7
H9GZV1 Uncharacterized 3 15.15 15.15 87.3 2.76E+05 (R)EPGQSVPTFAVTSLLR(V) 9.05 0.94 567.9708 -0.0192 -11.3 0.27%
protein
(Fragment)
(Immunoglobuli 2 18.58 18.58 93.4 4.08E+05 (K)GFFPLGFPEPVK(V) 9.48 0.99 667.8575 -0.0066 -5
n heavy chain)

100.00%

Peak 4
Database Protein Name z Score Fwd- SPI Spectral Sequence RT Average m/z Measured MH+ Mass MH+ Error Mean
Accession Rev (%) Intensity (min) Chi (Da) Shift (Da) (ppm) Spectral
Score Squated (protein % in
a fraction)

P35747 Serum albumin 2 18.02 18.02 86.9 2.02E+05 (K)ADFTECCPADDK(L) 4.77 0.98 714.7726 -0.0027 -1.9 0.25%
2 23.3 23.3 94.2 9.07E+04 (K)ECCHGDLLECADDR(A) 5.28 0.96 875.3311 -0.0076 -4.3
2 12.85 2.06 75.1 2.64E+05 (K)LCTVATLR(A) 5.3 0.99 467.2595 -0.0069 -7.4
3 15.12 15.12 79.2 7.81E+04 (K)ECCHGDLLECADDR(A) 5.28 0.86 583.8876 -0.0143 -8.2
3 12.75 6.45 90.8 1.04E+05 (K)SLHTLFGDK(L) 5.85 1 339.848 -0.0069 -6.8
3 18.18 18.18 90 2.84E+05 (K)LKPEPDAQCAAFQEDPD 6.67 1 835.4072 -0.0056 -2.2
KFLGK(Y)
4 10.7 10.7 70.9 9.17E+04 (R)RHPYFYGPELLFHAEEY 7.55 0.99 574.7824 -0.0108 -4.7
K(A)
3 13.86 13.86 82.7 4.52E+04 (R)RHPYFYGPELLFHAEEY 7.53 0.9 766.043 -0.0041 -1.8
K(A)
3 11.99 2.8 70.8 5.30E+04 (R)HPYFYGPELLFHAEEYK( 8.27 0.94 714.0092 -0.0044 -2.1
A)
H9GZU9 Uncharacterized 2 16.71 16.71 92.5 1.81E+05 (K)ALPAPVER(T) 4.92 1 426.7464 -0.0083 -9.7 40.22%
protein
(Fragment)
(Immunoglobuli 2 13.01 13.01 74.5 2.31E+05 (K)VSVTCLVK(D) 5.85 1 453.2571 -0.0055 -6.1
n heavy chain)
3 19.28 12.59 97.8 1.60E+05 (R)VVSVLPIQHQDWLSGK(E 7.57 0.99 602.6668 -0.005 -2.8
)
2 19.26 19.26 91.6 1.69E+07 (K)APDVFPLTICGNTPDPK( 7.85 0.9 921.4606 0.0037 2
V)
3 15.11 15.11 78.7 3.00E+07 (K)APDVFPLTICGNTPDPK( 7.77 1 614.6407 -0.0027 -1.4
V)
3 18.87 18.87 93.9 1.26E+06 (K)GDIHTFPLDLSNSAHHSL 7.95 0.92 940.7894 -0.0019 -0.7
SSMMAVPR(S)
3 21.42 21.42 100 1.31E+08 (K)VPVGCLVSNYFPEPVTV 9.4 0.94 951.1311 -0.0006 -0.2
SWNCDALK(G)
4 14.21 6.26 82.2 1.58E+07 (K)VPVGCLVSNYFPEPVTV 9.4 0.97 713.596 -0.0172 -6
SWNCDALK(G)

H9GZT5 Uncharacterized 2 19.54 19.54 92.1 1.49E+07 (K)SQTYICNVAHPASSTK(V 4.97 1 882.4201 -0.0052 -2.9 3.20%
protein )
(Fragment)
(Immunoglobuli 2 16.71 16.71 92.5 1.81E+05 (K)ALPAPVER(T) 4.92 1 426.7464 -0.0083 -9.7
n heavy chain)
2 13.01 13.01 74.5 2.31E+05 (K)VSVTCLVK(D) 5.85 1 453.2571 -0.0055 -6.1
3 15.91 15.91 79.9 8.62E+04 (R)EPQVYVLAPHRDELSK(N 5.87 0.99 627.6639 -0.0093 -5
)
2 14.5 14.5 81.5 7.31E+04 (K)YSTTPAQLDSDGSYFLYS 7.43 0.97 1071.9963 -0.0013 -0.6
K(L)

H9GZU8 Uncharacterized 2 19.54 19.54 92.1 1.49E+07 (K)SQTYICNVAHPASSTK(V 4.97 1 882.4201 -0.0052 -2.9 3.16%
protein )
(Fragment)
(Immunoglobuli 2 16.71 16.71 92.5 1.81E+05 (R)ALPAPVER(T) 4.92 1 426.7464 -0.0083 -9.7
n heavy chain)
2 19.54 13.78 97.7 6.63E+04 (R)IVIKEPCCCPK(C) 5.02 0.93 702.3409 -0.0099 -7
2 16.54 16.54 86.9 1.43E+05 (R)QSSGLYSLSSMVTVPASS 8.6 0.99 1021.5253 -0.0041 -2
LK(S)
F6V5H1 Uncharacterized 3 17.32 17.32 86.6 1.38E+05 (K)TSSFHSSLTEQDSK(D) 4.55 0.98 518.5707 -0.0103 -6.6 2.85%
protein
(Fragment)
(Immunoglobuli 2 20.13 20.13 95 7.37E+04 (K)TSSFHSSLTEQDSK(D) 4.55 0.97 777.3542 -0.0067 -4.3
n light chain)
3 16.99 16.99 76.8 3.41E+06 (K)ADYEAHNVYACEVSHK( 4.8 0.99 631.6113 -0.0038 -2
T)
2 23.3 23.3 94 1.14E+06 (K)ADYEAHNVYACEVSHK( 4.8 1 946.9128 -0.0049 -2.6
T)
2 14.61 8.26 91.4 4.54E+06 (K)TLSSPLVK(S) 5.38 0.96 422.7591 -0.0029 -3.5
2 14.03 14.03 81.9 4.52E+06 (K)DNTYSLSSTLTLPK(A) 7.45 1 770.398 -0.0014 -0.9

A0A0A1E4 Immmunoglobu 2 12.56 6.75 76.9 1.42E+05 (K)SYSSVSCQVK(H) 4.5 0.99 572.7643 -0.009 -7.8 5.78%
70 lin lambda light
chain variable
region
(Fragment)
2 20.83 20.83 92.5 5.50E+06 (K)VNDAVTTDGVQTTR(S) 4.6 0.86 738.8633 -0.0096 -6.5
2 15.79 15.79 84 2.43E+05 (K)VGWFQQIPGTAPK(T) 7.53 0.99 714.884 -0.0027 -1.9
2 17.22 12.15 93.5 2.21E+07 (K)ATVVCLISDFSPSGLEVI 10.77 1 1111.0759 -0.0128 -5.8
WK(V)

A0A0A1E3 Immmunoglobu 2 19.61 19.61 89.1 2.41E+05 (K)SYSSVSCQVTHQGK(T) 4.48 0.98 784.3562 -0.0118 -7.5 14.67%
V9 lin lambda light
chain variable
region
(Fragment)
2 20.34 20.34 87.2 1.99E+05 (K)LTQPSSVSVALGQTATIT 7.13 0.88 1031.5421 -0.008 -3.9
CK(G)
3 15.08 15.08 76.2 1.46E+05 (K)LTQPSSVSVALGQTATIT 7.12 0.88 688.0303 -0.0085 -4.1
CK(G)
2 21.72 15.97 100 2.59E+07 (K)ATVVCLISDFSPSDLTVS 10.13 1 1113.0601 -0.0029 -1.3
WK(G)
3 16.54 16.54 83.1 3.82E+07 (K)ATVVCLISDFSPSDLTVS 10.12 1 742.3729 -0.0117 -5.3
WK(G)
3 15.24 15.24 80 6.44E+06 (K)ATVVCLISDFSPSDLTVS 11.8 0.85 742.3737 -0.0093 -4.2
WK(G)
A0A0A1E6 Immmunoglobu 3 16.21 16.21 70.7 6.39E+05 (K)YAASSYLSLTPSQWK(S) 7.6 0.99 567.9527 -0.0047 -2.8 14.79%
I1 lin lambda light
chain variable
region
(Fragment)
2 18.3 15.2 93.3 5.93E+05 (R)LTIAGGPTSTPSVSLFPPS 8.27 0.98 1344.1935 0.0023 0.9
SEELSANK(A)
2 21.72 15.97 100 2.59E+07 (K)ATVVCLISDFSPSDLTVS 10.13 1 1113.0601 -0.0029 -1.3
WK(V)
3 16.54 16.54 83.1 3.82E+07 (K)ATVVCLISDFSPSDLTVS 10.12 1 742.3729 -0.0117 -5.3
WK(V)
3 15.24 15.24 80 6.44E+06 (K)ATVVCLISDFSPSDLTVS 11.8 0.85 742.3737 -0.0093 -4.2
WK(V)

A0A0A1E6 Immmunoglobu 2 18.73 18.73 86.1 3.32E+05 (K)VNGAAISQGVQTTKPSK( 4.57 0.98 843.4592 -0.007 -4.1 14.60%
P5 lin lambda light Q)
chain variable
region
(Fragment)
2 13.29 13.29 77.9 9.65E+03 (R)LSVLGGPTSAPSVSLFPPS 8.62 0.77 1336.1928 -0.0042 -1.6
SEELSANK(A)
2 21.72 15.97 100 2.59E+07 (K)ATVVCLISDFSPSDLTVS 10.13 1 1113.0601 -0.0029 -1.3
WK(V)
3 16.54 16.54 83.1 3.82E+07 (K)ATVVCLISDFSPSDLTVS 10.12 1 742.3729 -0.0117 -5.3
WK(V)
3 15.24 15.24 80 6.44E+06 (K)ATVVCLISDFSPSDLTVS 11.8 0.85 742.3737 -0.0093 -4.2
WK(V)

F6W2Y1 Uncharacterized 2 13.65 13.65 76.5 5.61E+04 (R)DNCCILDER(F) 5.42 0.98 597.7446 -0.0059 -4.9 0.25%
protein
(Fibrinogen 3 13.93 8.46 73.7 3.68E+05 (K)DLQDFEDILHR(A) 7.97 0.99 467.5626 -0.0072 -5.2
chain)
2 18.68 18.68 88.8 4.41E+05 (K)DLQDFEDILHR(A) 7.97 0.98 700.8413 -0.0051 -3.7
2 28.57 28.57 96.1 1.47E+05 (R)FGSYCPTTCGIADFLSNY 9.03 0.97 1366.1032 -0.0023 -0.8
QTSVDK(D)
3 15.66 15.66 71.9 2.08E+05 (R)FGSYCPTTCGIADFLSNY 9.03 0.99 911.0707 -0.0039 -1.4
QTSVDK(D)
H9GZS9 Uncharacterized 3 15.12 15.12 88.9 4.50E+05 (K)TYICNVAHPASSTK(V) 4.68 0.99 516.9182 -0.0075 -4.8 0.20%
protein
(Fragment)
(Immunoglobuli 2 17.99 17.99 89 2.81E+05 (K)TYICNVAHPASSTK(V) 4.68 0.99 774.8737 -0.0074 -4.8
n light chain)
2 13.01 13.01 74.5 2.31E+05 (K)VSVTCLVK(D) 5.85 1 453.2571 -0.0055 -6.1

F6Z2L5 Uncharacterized 2 13.42 13.42 76.9 6.83E+04 (K)VAPLSDEFR(E) 6.1 0.99 517.2707 0.0028 2.7 0.04%
protein
(Apolipoprotein 2 16.62 9.2 80 1.21E+05 (K)LLDNWDSLGTTLGK(L) 8.12 0.98 766.9 -0.0028 -1.8
A-1)

100.00%

Peak 5
Database Protein Name z Score Fwd- SPI Spectral Sequence RT Average m/z (Da) MH+ Mass MH+ Error Mean
Accession Rev (%) Intensity (min) Chi Shift (Da) (ppm) Spectral
Score Squated (protein % in
a fraction)

P35747 Serum albumin 3 12.21 12.21 70.2 1.53E+05 (K)YICEHQDSISGK(L) 4.4 0.97 479.5479 -0.0183 -12.7 33.19%
2 17.83 17.83 77.6 4.42E+03 (K)YICEHQDSISGK(L) 4.4 0.6 718.822 -0.0107 -7.5
2 21.12 21.12 89.2 1.83E+06 (K)ADFTECCPADDK(L) 4.65 0.92 714.78 0.0121 8.5
3 14.78 14.78 71.6 4.00E+05 (K)ADFTECCPADDK(L) 4.57 0.99 476.8503 -0.0043 -3
2 18.64 18.64 82.1 2.50E+06 (R)ATYGELADCCEK(Q) 4.75 0.95 708.7914 -0.0015 -1
3 15.55 4.68 91.4 2.65E+05 (K)QEPERNECFLTHKDDHP 4.75 1 868.7468 -0.0001 0
NLPK(L)
2 23.81 23.81 89.1 1.37E+07 (K)ECCHGDLLECADDR(A) 5.02 0.95 875.3341 -0.0016 -0.9
3 18.72 18.72 97.6 1.30E+07 (K)ECCHGDLLECADDR(A) 5.02 0.95 583.8912 -0.0035 -2
2 13.75 13.75 75.3 6.41E+05 (K)LCTVATLR(A) 4.93 1 467.2613 -0.0033 -3.5
2 17.04 10.18 81.4 2.58E+05 (K)CSSFQNFGER(A) 4.98 1 616.2599 -0.0035 -2.9
3 22.65 13.72 100 4.16E+06 (K)LKPEPDAQCAAFQEDPD 5.2 0.92 686.9867 0.0019 0.9
K(F)
2 24.79 17.11 93.6 7.29E+06 (K)LKPEPDAQCAAFQEDPD 5.27 0.99 1029.9761 0.0012 0.6
K(F)
4 12.48 12.48 82 3.44E+05 (K)ECCHGDLLECADDRADL 5.6 0.98 562.7397 -0.0058 -2.6
AK(Y)
3 20.62 20.62 100 2.60E+05 (K)ECCHGDLLECADDRADL 5.62 0.98 749.9848 -0.0029 -1.3
AK(Y)
3 12.12 6.43 79.7 1.30E+06 (K)SLHTLFGDK(L) 5.67 1 339.8482 -0.0063 -6.2
2 19.02 9.11 92.9 1.32E+06 (K)SLHTLFGDK(L) 5.68 1 509.2697 -0.0042 -4.2
2 21.5 21.5 92.4 4.28E+05 (K)ECCHGDLLECADDRADL 5.78 0.99 1124.4721 -0.0058 -2.6
AK(Y)
3 13.54 13.54 85 2.16E+05 (R)RHPDYSVSLLLR(I) 6.38 0.99 485.9382 -0.0066 -4.6
2 20.06 20.06 92 1.44E+06 (K)LKPEPDAQCAAFQEDPD 6.48 1 1252.61 0.0001 0
KFLGK(Y)
2 13.31 6.02 80.9 8.64E+04 (R)RHPDYSVSLLLR(I) 6.38 0.98 728.4056 -0.0027 -1.9
5 11.55 3.48 78.4 5.65E+05 (K)LKPEPDAQCAAFQEDPD 6.52 0.99 501.6464 -0.0097 -3.9
KFLGK(Y)
3 13.57 13.57 78.6 4.63E+04 (R)HPDYSVSLLLR(I) 7.23 1 433.9035 -0.0096 -7.4
3 12.7 7.63 82.9 4.23E+04 (R)RPCFSALELDEGYVPK(E) 7.2 0.9 627.6464 0.0035 1.9
2 15.58 15.58 88.8 1.50E+06 (R)RHPYFYGPELLFHAEEY 7.57 0.99 1148.562 -0.0018 -0.8
K(A)
3 16.4 16.4 83.2 1.12E+07 (R)HPYFYGPELLFHAEEYK( 8.23 0.99 714.0094 -0.0038 -1.8
A)
2 14.44 4.88 84.4 2.22E+05 (K)TVLGNFSAFVAK(C) 8.13 1 627.3468 -0.0025 -2
2 18.3 11.08 75.4 9.28E+05 (R)HPYFYGPELLFHAEEYK( 8.22 0.99 1070.5112 -0.0023 -1.1
A)
3 14.66 8.32 87.4 8.13E+05 (K)EDDLPSDLPALAADFAE 9.02 1 854.7339 -0.0044 -1.7
DKEICK(H)
2 17.21 13.11 94 1.09E+04 (K)EDDLPSDLPALAADFAE 9.02 0.79 1281.5988 -0.0013 -0.5
DKEICK(H)
 2 18.87 18.87 96.7 1.34E+05 (K)EDDLPSDLPALAADFAE 9.32 0.96 1016.4719 -0.0028 -1.4
DK(E)
3 13.66 13.66 79.8 5.85E+03 (K)EDDLPSDLPALAADFAE 9.32 0.59 677.9821 -0.0076 -3.7
DK(E)
2 16.91 9.8 84.6 3.76E+06 (K)DVFLGTFLYEYSR(R) 9.85 0.99 805.397 -0.003 -1.8
3 15.07 6.64 86.7 4.44E+05 (K)DVFLGTFLYEYSR(R) 9.83 0.88 537.2648 -0.0098 -6.1
3 18.17 7.09 92.6 1.38E+06 (K)GLVLVAFSQYLQQCPFE 9.87 1 826.7528 -0.0047 -1.9
DHVK(L)
4 14.34 2.68 82.3 3.30E+05 (K)GLVLVAFSQYLQQCPFE 9.87 0.99 620.3161 -0.006 -2.4
DHVK(L)
2 13.32 6.23 76.1 1.16E+05 (K)GLVLVAFSQYLQQCPFE 9.87 0.92 1239.6219 -0.0121 -4.9
DHVK(L)

Q5XLE4 Serum albumin 3 12.21 12.21 70.2 1.53E+05 (K)YICEHQDSISGK(L) 4.4 0.97 479.5479 -0.0183 -12.7 33.56%
2 17.83 17.83 77.6 4.42E+03 (K)YICEHQDSISGK(L) 4.4 0.6 718.822 -0.0107 -7.5
2 21.12 21.12 89.2 1.83E+06 (K)ADFTECCPADDK(A) 4.65 0.92 714.78 0.0121 8.5
3 14.78 14.78 71.6 4.00E+05 (K)ADFTECCPADDK(A) 4.57 0.99 476.8503 -0.0043 -3
2 18.64 18.64 82.1 2.50E+06 (R)ATYGELADCCEK(Q) 4.75 0.95 708.7914 -0.0015 -1
3 15.55 4.68 91.4 2.65E+05 (K)QEPERNECFLTHKDDHP 4.75 1 868.7468 -0.0001 0
NLPK(L)
2 23.81 23.81 89.1 1.37E+07 (K)ECCHGDLLECADDR(A) 5.02 0.95 875.3341 -0.0016 -0.9
3 18.72 18.72 97.6 1.30E+07 (K)ECCHGDLLECADDR(A) 5.02 0.95 583.8912 -0.0035 -2
2 13.75 13.75 75.3 6.41E+05 (K)LCTVATLR(A) 4.93 1 467.2613 -0.0033 -3.5
3 22.65 13.72 100 4.16E+06 (K)LKPEPDAQCAAFQEDPD 5.2 0.92 686.9867 0.0019 0.9
K(F)
2 24.79 17.11 93.6 7.29E+06 (K)LKPEPDAQCAAFQEDPD 5.27 0.99 1029.9761 0.0012 0.6
K(F)
3 12.12 6.43 79.7 1.30E+06 (K)SLHTLFGDK(L) 5.67 1 339.8482 -0.0063 -6.2
2 19.02 9.11 92.9 1.32E+06 (K)SLHTLFGDK(L) 5.68 1 509.2697 -0.0042 -4.2
2 14.56 7.15 76.9 9.55E+04 (K)ADFTECCPADDKAGCLI 6.13 0.99 1084.4755 -0.002 -0.9
PK(L)
3 13.54 13.54 85 2.16E+05 (R)RHPDYSVSLLLR(I) 6.38 0.99 485.9382 -0.0066 -4.6
 2 20.06 20.06 92 1.44E+06 (K)LKPEPDAQCAAFQEDPD 6.48 1 1252.61 0.0001 0
KFLGK(Y)
2 13.31 6.02 80.9 8.64E+04 (R)RHPDYSVSLLLR(I) 6.38 0.98 728.4056 -0.0027 -1.9
5 11.55 3.48 78.4 5.65E+05 (K)LKPEPDAQCAAFQEDPD 6.52 0.99 501.6464 -0.0097 -3.9
KFLGK(Y)
3 13.57 13.57 78.6 4.63E+04 (R)HPDYSVSLLLR(I) 7.23 1 433.9035 -0.0096 -7.4
2 15.58 15.58 88.8 1.50E+06 (R)RHPYFYGPELLFHAEEY 7.57 0.99 1148.562 -0.0018 -0.8
K(A)
3 16.4 16.4 83.2 1.12E+07 (R)HPYFYGPELLFHAEEYK( 8.23 0.99 714.0094 -0.0038 -1.8
A)
2 14.44 4.88 84.4 2.22E+05 (K)TVLGNFSAFVAK(C) 8.13 1 627.3468 -0.0025 -2
2 18.3 11.08 75.4 9.28E+05 (R)HPYFYGPELLFHAEEYK( 8.22 0.99 1070.5112 -0.0023 -1.1
A)
3 14.66 8.32 87.4 8.13E+05 (K)EDDLPSDLPALAADFAE 9.02 1 854.7339 -0.0044 -1.7
DKEICK(H)
2 17.21 13.11 94 1.09E+04 (K)EDDLPSDLPALAADFAE 9.02 0.79 1281.5988 -0.0013 -0.5
DKEICK(H)
2 18.87 18.87 96.7 1.34E+05 (K)EDDLPSDLPALAADFAE 9.32 0.96 1016.4719 -0.0028 -1.4
DK(E)
3 13.66 13.66 79.8 5.85E+03 (K)EDDLPSDLPALAADFAE 9.32 0.59 677.9821 -0.0076 -3.7
DK(E)
3 16.54 16.54 83.8 1.61E+06 (K)CCAEADPPACYATVFDQ 9.5 0.96 1005.7779 -0.0018 -0.6
FTPLVEEPK(S)
2 21.46 21.46 94.4 4.59E+05 (K)CCAEADPPACYATVFDQ 9.48 0.97 1508.1608 -0.0066 -2.2
FTPLVEEPK(S)
2 16.91 9.8 84.6 3.76E+06 (K)DVFLGTFLYEYSR(R) 9.85 0.99 805.397 -0.003 -1.8
3 15.07 6.64 86.7 4.44E+05 (K)DVFLGTFLYEYSR(R) 9.83 0.88 537.2648 -0.0098 -6.1
3 18.17 7.09 92.6 1.38E+06 (K)GLVLVAFSQYLQQCPFE 9.87 1 826.7528 -0.0047 -1.9
DHVK(L)
4 14.34 2.68 82.3 3.30E+05 (K)GLVLVAFSQYLQQCPFE 9.87 0.99 620.3161 -0.006 -2.4
DHVK(L)
2 13.32 6.23 76.1 1.16E+05 (K)GLVLVAFSQYLQQCPFE 9.87 0.92 1239.6219 -0.0121 -4.9
DHVK(L)

F6RI47 Uncharacterized 3 13.18 13.18 72.9 3.15E+05 (K)MVSGFVPLKPTVK(T) 6.33 1 468.2731 -0.0079 -5.6 2.04%
protein
(alpha-2- 2 15.44 15.44 85.8 9.70E+04 (K)MVSGFVPLKPTVK(T) 6.35 0.99 701.9081 -0.0037 -2.7
macroglobulin
like)
 2 25.5 25.5 100 6.76E+05 (K)VYDYYETDEFAIAEYNA 7.78 0.99 1259.5375 -0.0078 -3.1
PCGK(D)
3 21.37 21.37 100 7.65E+05 (K)VYDYYETDEFAIAEYNA 7.8 1 840.0261 -0.0118 -4.7
PCGK(D)
2 12.86 5.4 77.2 9.03E+03 (K)DTIIKPLLVEPEGLEK(E) 7.87 0.72 897.5112 -0.0108 -6
3 14.87 9.03 91.8 8.02E+05 (K)EKFPFALEVQTLPQTCEG 8 1 770.3861 -0.0045 -1.9
SK(A)
2 23.4 23.4 100 1.45E+05 (K)EKFPFALEVQTLPQTCEG 8 0.98 1155.0746 -0.0063 -2.7
SK(A)
2 14.88 5.53 80.2 5.14E+04 (R)SLFTDLVAEK(D) 7.3 1 561.8026 -0.0062 -5.5
2 20.62 16.2 100 8.15E+04 (K)FPFALEVQTLPQTCEGSK 8.45 1 1026.5085 -0.0009 -0.5
(A)
3 14.45 8.85 82.6 1.43E+06 (K)FPFALEVQTLPQTCEGSK 8.55 1 684.6735 -0.0047 -2.3
(A)
3 13.11 13.11 79.8 5.70E+03 (K)DLFHCVSFIVPR(A) 8.87 0.96 497.2556 -0.0098 -6.6
3 19.44 19.44 89.3 6.77E+03 (K)VYDYYETDEFAIAEYNA 10.35 0.81 840.0261 -0.0118 -4.7
PCGK(D)

F6USP9 Uncharacterized 2 20.01 11.73 86.4 3.64E+05 (R)CSTPPPSSGPTYQCLK(G) 5.05 0.98 890.4044 -0.0025 -1.4 1.24%
protein
(Fragment)
(Plasminogen) 3 17.76 17.76 80.4 4.97E+05 (K)YSPDKNPSEGLEENYCR( 5.1 0.99 686.633 -0.0025 -1.2
N)
2 22.9 22.9 100 2.93E+05 (K)YSPDKNPSEGLEENYCR( 5.12 0.99 1029.4448 -0.0046 -2.2
N)
2 18.8 18.8 93.8 2.47E+05 (K)GPWCYTTDPGTR(F) 5.78 1 705.8079 -0.0022 -1.5
3 19.11 12.05 97.8 3.49E+05 (R)NPDNDEKGPWCYTTDPG 5.88 0.99 741.6507 -0.0032 -1.4
TR(F)
2 21.9 16.83 100 1.05E+05 (R)NPDNDEKGPWCYTTDPG 5.9 0.99 1111.9718 -0.0044 -2
TR(F)
4 15.23 7 86.7 4.05E+05 (K)TISGLECQPWASQSPHA 6.15 0.99 663.5707 -0.0061 -2.3
HGYIPSK(F)
3 17.17 9.63 94.2 9.26E+04 (K)TISGLECQPWASQSPHA 6.13 0.98 884.4252 -0.006 -2.3
HGYIPSK(F)
2 19.7 19.7 92.8 3.01E+05 (R)NPDGETAPWCYTTSSET 6.18 0.99 1036.4364 -0.0007 -0.3
R(W)

P07589 Fibronectin 2 12.38 1.02 81.8 1.14E+05 (R)ITGYIIK(Y) 5.48 1 404.2488 -0.0071 -8.8 1.55%
2 15.72 8.34 95.9 7.14E+05 (R)SYTITGLQPGTDYK(I) 6.18 0.99 772.3846 -0.0019 -1.3
 2 15.56 15.56 76.6 8.92E+04 (K)YEVSVYALK(D) 6.33 1 536.2874 -0.0046 -4.3
3 16.18 9.7 92.7 1.96E+05 (R)VDVIPVNLPGEHGQR(L) 6.92 0.97 543.9588 -0.0089 -5.5
2 19.9 8.66 90 5.62E+05 (R)TFYQIGDSWEK(Y) 7.07 0.99 687.32 -0.0045 -3.3
3 11.72 5.99 71.1 9.12E+04 (R)NTFAEVTGLSPGVTYHF 7.37 0.98 656.6636 -0.0099 -5
K(V)
3 19.31 19.31 91.9 9.07E+05 (K)FTQVTPTSLTAQWTAPN 8.6 0.99 894.128 -0.0035 -1.3
VQLTGYR(V)
2 26.62 20.4 97.8 6.36E+05 (K)FTQVTPTSLTAQWTAPN 8.6 0.98 1340.6893 -0.0016 -0.6
VQLTGYR(V)

Q28377 Fibronectin 2 12.38 1.02 81.8 1.14E+05 (R)ITGYIIK(Y) 5.48 1 404.2488 -0.0071 -8.8 1.69%
(Fragment)
2 15.72 8.34 95.9 7.14E+05 (R)SYTITGLQPGTDYK(I) 6.18 0.99 772.3846 -0.0019 -1.3
2 15.56 15.56 76.6 8.92E+04 (-)YEVSVYALK(D) 6.33 1 536.2874 -0.0046 -4.3
2 17.36 9.05 88 2.50E+06 (K)IYLYTLNDNAR(S) 6.73 0.99 678.3488 -0.0051 -3.7
3 17.84 10.4 86.6 1.39E+05 (R)TKTETITGFQVDAVPAN 6.83 0.98 856.7827 -0.0081 -3.2
GQPPIQR(T)
2 23.38 17.65 98.4 4.53E+04 (K)TETITGFQVDAVPANGQ 7.17 0.98 1170.1006 -0.0051 -2.2
PPIQR(T)
3 14.69 8.3 86.5 1.22E+04 (R)SYTITGLQPGTDYKIYLY 8.45 0.69 960.8155 -0.0095 -3.3
TLNDNAR(S)

P11276 Fibronectin 2 16.18 16.18 72.7 3.73E+04 (K)CDPIDQCQDSETR(T) 4.47 1 812.3171 -0.0104 -6.4 0.72%
2 12.38 1.02 81.8 1.14E+05 (R)ITGYIIK(Y) 5.48 1 404.2488 -0.0071 -8.8
2 15.72 8.34 95.9 7.14E+05 (R)SYTITGLQPGTDYK(I) 6.18 0.99 772.3846 -0.0019 -1.3
2 15.56 15.56 76.6 8.92E+04 (K)YEVSVYALK(D) 6.33 1 536.2874 -0.0046 -4.3
2 11.76 11.76 83.1 2.06E+04 (R)TYLGNALVCTCYGGSR( 6.88 0.75 896.4053 -0.0119 -6.7
G)
2 19.9 8.66 90 5.62E+05 (R)TFYQIGDSWEK(F) 7.07 0.99 687.32 -0.0045 -3.3

H9GZN9 Uncharacterized 2 17.27 17.27 88.8 5.03E+05 (R)LVCQATGFSPK(E) 5 0.99 604.3086 -0.004 -3.4 1.08%
protein
(Fragment)
(Immunoglobuli 2 17.9 17.9 86.3 1.45E+05 (R)DGKPVESGFTTEEVQPQ 5.22 0.95 1045.5046 -0.0017 -0.8
ln heavy chain) NK(E)
 2 11.87 11.87 79.7 1.93E+05 (K)ESWPVTYK(V) 6 1 505.251 -0.0042 -4.2
2 11.98 11.98 76.7 2.56E+05 (K)NFPSVLR(E) 6.18 1 416.7353 -0.0042 -5.1
2 12.63 1.63 80.7 2.86E+05 (K)EISVSWLR(D) 7.37 1 495.2722 -0.0043 -4.4
2 16.07 16.07 84.4 6.79E+04 (K)VTSMLTITESDWLNQK( 8.72 0.88 933.467 -0.0046 -2.5
V)
3 12.25 12.25 74.8 7.01E+05 (K)TPDLFPLVSCGPSLDESL 10.48 0.99 925.1328 -0.0061 -2.2
VAVGCLAR(D)
2 21.67 21.67 100 1.70E+05 (K)TPDLFPLVSCGPSLDESL 10.47 0.97 1387.1937 -0.0098 -3.5
VAVGCLAR(D)

P27425 Serotransferrin 2 21.9 21.9 86.2 1.36E+06 (K)AACVCQELHNQQASYG 4.7 0.98 982.4411 0 0 1.03%
K(N)
3 16.13 16.13 82.3 1.54E+04 (R)LLEACTFHR(V) 4.88 0.96 382.8608 -0.0046 -4
3 19.3 19.3 95.9 4.33E+05 (K)CDEWSVNSGGNIECESA 6.65 0.92 982.7287 -0.0107 -3.6
QSTEDCIAK(I)
2 24.94 24.94 87.4 1.30E+04 (K)CDEWSVNSGGNIECESA 6.42 0.73 1473.5929 -0.0037 -1.3
QSTEDCIAK(I)
2 14.14 7.98 85.1 1.06E+04 (K)SSSDPDLTWNSLK(G) 6.97 0.19 725.3438 -0.0053 -3.6
2 17.19 17.19 89.7 3.73E+05 (K)GEADAMSLDGGFIYIAG 8.68 0.98 907.934 -0.0022 -1.2
K(C)

H9GZU9 Uncharacterized 2 15 15 76.2 2.52E+05 (K)VSVTCLVK(D) 5.8 1 453.2578 -0.0041 -4.6 12.84%
protein
(Fragment)
(Immunoglobul 2 16.96 12.2 98 8.46E+04 (R)VVSVLPIQHQDWLSGK(E 7.58 0.99 903.4975 -0.0031 -1.7
in heavy chain) )
3 18.86 18.86 91.3 2.15E+05 (K)DFYPPEIDVEWQSNEHPE 7.75 0.88 881.3926 -0.0049 -1.9
PEGK(Y)
2 14.06 14.06 89.5 3.52E+06 (K)APDVFPLTICGNTPDPK( 7.95 1 921.4582 -0.0011 -0.6
V)
3 15.5 15.5 79.8 1.11E+06 (K)APDVFPLTICGNTPDPK( 7.93 1 614.6393 -0.0069 -3.7
V)
3 22.42 22.42 100 1.57E+07 (K)VPVGCLVSNYFPEPVTV 9.57 0.98 951.1299 -0.0042 -1.5
SWNCDALK(G)
2 21.65 21.65 97.1 5.16E+06 (K)VPVGCLVSNYFPEPVTV 9.57 0.97 1426.1935 0.0004 0.1
SWNCDALK(G)
4 13.53 4.21 87.1 1.77E+06 (K)VPVGCLVSNYFPEPVTV 9.57 0.98 713.5967 -0.0144 -5
SWNCDALK(G)
A0A0A1E4 Immmunoglobu 2 20 20 90.8 1.77E+06 (K)VNDAVTTDGVQTTR(S) 4.52 0.99 738.8674 -0.0014 -0.9 3.22%
70 lin lambda light
chain variable
region
(Fragment)
2 14.89 7.46 78.3 2.45E+06 (K)YAASSYLTR(T) 4.92 1 516.2608 -0.0013 -1.3
2 14.72 14.72 80.1 5.99E+04 (K)VGWFQQIPGTAPK(T) 7.42 0.98 714.8834 -0.0039 -2.7
2 19.55 19.55 96 2.62E+06 (K)ATVVCLISDFSPSGLEVI 10.8 1 1111.0746 -0.0154 -6.9
WK(V)

F6SQD7 Uncharacterized 2 14.89 7.46 78.3 2.45E+06 (K)YAASSYLTR(T) 4.92 1 516.2608 -0.0013 -1.3 3.76%
protein
(Fragment)
(Immunoglobuli 2 19.93 19.93 93.4 2.15E+06 (K)ATVVCLISDFSPSDLTVS 10.2 1 1113.0549 -0.0133 -6
n light chain) WK(V)
3 16.25 16.25 84.1 3.47E+06 (K)ATVVCLISDFSPSDLTVS 10.2 1 742.3721 -0.0141 -6.3
WK(V)

F7C0Z0 Uncharacterized 3 20.07 20.07 90.4 1.40E+05 (R)ECDYKDPEQAATGECTA 5.1 0.99 786.6708 0.0006 0.2 0.14%
protein TVGR(R)
(Kininogen-1) 2 22.29 22.29 97.9 3.62E+04 (R)ECDYKDPEQAATGECTA 5.1 0.91 1179.5018 -0.0009 -0.4
TVGR(R)
2 16.47 16.47 74.5 1.03E+05 (K)YNQGNQSGYQFVLYR(I) 7.13 0.89 918.9337 -0.0062 -3.4
2 16.4 9.36 86.7 3.02E+04 (K)ENFLFLTPDCK(S) 8.17 0.96 692.332 -0.0046 -3.3

P04365 Inter-alpha- 2 23.65 16.63 98.4 1.53E+05 (R)TVAACNLPIVQGPCR(A) 6.32 0.99 828.4203 -0.0023 -1.4 0.11%
trypsin inhibitor
(Fragment)
2 13.64 5.62 75.1 8.16E+04 (K)CVLFTYGGCR(G) 6.32 0.99 616.78 -0.0024 -1.9

A0A0A1E6 Immmunoglobu 2 15.81 15.81 86.6 1.21E+04 (R)LTIAGGPTSTPSVSLFPPS 8.23 0.79 1344.1889 -0.0069 -2.6 2.77%
I1 lin lambda light SEELSANK(A)
chain variable
region
(Fragment)
3 15.43 15.43 83 3.04E+05 (R)LTIAGGPTSTPSVSLFPPS 8.28 0.88 896.4627 -0.0039 -1.4
SEELSANK(A)
 2 19.93 19.93 93.4 2.15E+06 (K)ATVVCLISDFSPSDLTVS 10.2 1 1113.0549 -0.0133 -6
WK(V)
3 16.25 16.25 84.1 3.47E+06 (K)ATVVCLISDFSPSDLTVS 10.2 1 742.3721 -0.0141 -6.3
WK(V)

H9GZT5 Uncharacterized 2 19.55 19.55 92.1 2.36E+05 (K)SQTYICNVAHPASSTK(V 4.7 0.99 882.4218 -0.0018 -1 0.23%
protein )
(Fragment)
(Immunoglobuli 2 15 15 76.2 2.52E+05 (K)VSVTCLVK(D) 5.8 1 453.2578 -0.0041 -4.6
n heavy chain)

O97678 Transferrin 3 18.85 15.55 89.6 2.48E+05 (K)AVTEFESCNLAEAPNHA 6.08 1 767.7001 -0.0071 -3.1 0.19%
(Fragment) VVSR(K)
2 15.32 15.32 90.4 1.64E+05 (K)SGNFQLLCPDGTR(K) 6.57 0.98 732.8465 -0.0043 -2.9

F6ZEH8 Serotransferrin 2 15.62 8.9 89.5 9.50E+04 (K)AVTEFESCNLAK(A) 5.68 1 684.8246 -0.0045 -3.3 0.12%
2 15.32 15.32 90.4 1.64E+05 (K)SGNFQLLCPDGTR(K) 6.57 0.98 732.8465 -0.0043 -2.9

F6W2Y1 Uncharacterized 2 14.77 14.77 77.1 8.26E+04 (R)DNCCILDER(F) 5.33 0.99 597.7453 -0.0045 -3.7 0.05%
protein
(Fibrinogen) 2 19.37 14.12 100 2.79E+04 (K)DLQDFEDILHR(A) 8.02 0.99 700.8404 -0.0069 -5

F6RMD0 Uncharacterized 2 12.47 12.47 71.1 2.04E+05 (R)CYDGYTLR(G) 4.9 1 524.2302 -0.0033 -3.1 0.43%
protein
(Complement 2 19.23 13.49 93.4 7.23E+05 (R)LEDSVTYYCSR(G) 5.45 0.99 696.8061 -0.0051 -3.7
factor B)

F6QFD9 Uncharacterized 3 15.82 15.82 76 1.88E+04 (R)CTYSNPEGTVVLACDEV 6.8 0.96 786.6708 -0.018 -7.7 0.04%
protein QCR(W)
(Carboxypeptid 2 18.22 18.22 82.8 2.97E+04 (R)CTYSNPEGTVVLACDEV 6.78 0.9 1179.5018 -0.0196 -8.3
ase) QCR(W)
2 13.35 13.35 76.6 4.00E+04 (R)WLNIQLSPR(Q) 7.52 0.88 563.8194 -0.0052 -4.6

100.00%